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Chapter 1
Introduction
1.1 Immune system
Over the past million years, a powerful and highly sophisticated system has
evolved to protect our bodies from microbes, toxins and other pathogens,
that surround us constantly. This system of defense — composed of a com-
plex network of soluble factors and cells — is called “the immune system”.
A central feature of the immune system is its ability to distinguish between
harmless “self” and pathogenic “non-self” structures, in order to only mount
immune responses against potentially dangerous, foreign antigens.
An immune response can generally be divided into two phases; an initial
phase of recognition, responsible for the selectivity of the reaction, followed
by an effector phase. To reach selectivity and thus to prevent a reaction
against autologous cells, pathogen recognition is based upon the presence of
characteristic “foreign” markers and the concomitant absence of particular
markers, expressed by “self”-tissue (Medzhitov and Janeway, 2002). During
the effector phase, diverse highly efficient mechanisms are activated, aim-
ing for the destruction and elimination of the intruding pathogens. These
potentially lethal mechanisms have developed from the continuous threat
by pathogens and are extremely potent and dangerous. Therefore, a tight
regulation of the immune response is of great significance to restrict its ef-
fects to harmful substances. Numerous examples of humans with a defective
immunity illustrate how important a perfectly balanced immune system is;
a lack of immunity tends to result in an increased susceptibility to infec-
tious diseases; such as in case of severe combined immunodeficiency (SCID).
Conversely, an excessive and overshooting immune response directed against
self-antigens can lead to severe autoimmune diseases, like Lupus erythemy-
tosus. Finally, an inappropriate reaction against otherwise harmless sub-
stances can be the origin of allergies.
Knowledge about the fundamental principles of the immune system has
also enabled us to benefit from its strength. The well-directed application
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of specifically chosen, small doses of antigen, i.e. a “vaccine”, can generate
immunological memory that thus helps us to be protected from experiencing
serious illnesses.
Globally, the immune system can be subdivided into two evolutionary
different branches: the “innate” and the “adaptive” immune system. These
two systems can be discriminated by the main players involved, their im-
mune receptors and therefore the speed and specificity of the reaction. Al-
though both systems are very closely linked and in certain areas even seam-
lessly merged, this division helps to illustrate the different general strategies
and mechanisms through which we are able to protect and defend ourselves
against pathogens or infectious diseases.
1.1.1 Innate immune system
The variety of immunological processes that are to our disposal without any
previous exposition to microbes are summarized under the term “innate im-
munity”. Through a number of fixed germ-line encoded receptors, patterns
of microbial or viral structures are recognized in order to activate defense
mechanisms. Prior to the activation of any of these mechanisms, pathogens
need to overcome the first line of defense, represented by tight epithelial cell
layers in the skin and mucosal membranes. In addition to these physical bar-
riers, the synthesis of antimicrobial proteins and maintenance of an acidic
environment are effective chemical means for the earliest elimination of mi-
crobes. Once pathogens succeed in intruding into the epithelium, different
strategies take action that are known as second line of defense. The recruit-
ment of immune cells, such as macrophages, neutrophils, eosinophils, natu-
ral killer cells (NK cells) and dendritic cells (DC) plays a major role here.
Through pattern recognition receptors (PRR), these cells are able to detect
vital components of foreign pathogens referred to as pathogen-associated
molecular patterns (PAMPs), which are shared by groups of related mi-
crobes but are inexistent in healthy host cells. PAMPs are usually very
essential molecules for the survival and function of the pathogen, includ-
ing mannans, present in the yeast cell wall, double-stranded RNA (dsRNA)
from viruses, bacterial and viral unmethylated CpG DNA and various bac-
terial cell-wall components such as lipopolysaccharides (LPS), lipopeptides,
peptidoglycans and teichoic acids (Tsan and Gao, 2004).
The first PRRs that have been characterized are the so-called Toll-like
receptors (TLR) (Medzhitov et al., 1997; Takeda et al., 2003), of which ten
(named TLR1-10) are currently known to be expressed in humans. Together
with the other PRRs, they can be classified according to their ability to pro-
mote either of two principal immune reactions: the initiation of phagocytosis
or the activation of pro-inflammatory pathways via the release of cytokines
and interferones. In neutrophils, monocytes, macrophages, mast cells and
DCs, activation of PRRs leads directly to phagocytosis of the recognized
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pathogen. Beside the removal of the perturbing agent, phagocytosis ren-
ders these cells also able to recruit cells of the adaptive immune system by
presenting parts of the engulfed structures to them.
Another non-cellular component of innate immunity is the complement
system (Ricklin et al., 2010). This system comprises a compilation of plasma
proteins, which initiate a cascade of proteolytic reactions after mannose- or
antibody-binding. The binding is achieved by covering the microbial surfaces
with fragments that can be bound by phagocytic receptors on macrophages.
Since the plasmatic molecules that facilitate phagocytosis are called op-
sonins, this special way of cellular removal is termed opsonisation. Some
opsonins represent also targets for cellular destruction through activation of
NK cells, whereas other components of the complement system contribute to
the attraction of neutrophils and macrophages via their activity as chemo-
tactic agents.
Together, these processes dominate the reaction against pathogens for
the first four to five days and provide thus the early defense against infec-
tions. However, already during this initial phase of defense, several innate
immune mechanisms aim for the activation and priming of the adaptive im-
mune response, such as the release of inflammatory cytokines or the presen-
tation of pathogenic antigens that have been processed after phagocytosis.
Thereby, the innate immune system achieves to overcome its limitations of
having only a restricted repertoire of pathogen recognition and lacking the
ability to form a long-lasting memory against newly encountered pathogens,
through the rapid involvement of the adaptive immune response.
1.1.2 Adaptive immune system
In contrast to the innate immunity, the adaptive immune system is an evo-
lutionary young defense strategy, which is only present in vertebrates and
cartilaginous fish. It is characterized by the specific immune response that
is mounted after activation of unique antigen recognition receptors. These
receptors are present on thymus-derived lymphocytes (T-cells) or bursa-
derived lymphocytes (B-cells). They have undergone somatic gene recombi-
nation in order to provide each immune cell with the ability to recognize an
exclusive antigen. Moreover, due to a process called allelic exclusion, only
one of the two inherited alleles for the immune receptor is expressed in the
process of successful rearrangement. As a result, mature B-cells or T-cells
only express a single antigen receptor specificity. This specificity for a single
receptor requires an exceptionally high diversity of immune receptors for
the recognition of theoretically any potential pathogen or toxin. There are
approximately 2 x 107 different T-cell receptors (TCR) at any given time
point in a human.
T-cells and B-cells are the major cellular components of the adaptive
immune system. They arise from a common haematopoietic stem cell that
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is generated in the bone marrow. Resident stem cells in the bone marrow
are able to directly differentiate into the B-cell lineage. Stem cells that are
released into the blood, can, however, enter the thymus, where they en-
counter a unique microenvironment promoting the initiation and support of
T-cells. In addition to these two primary sites of lymphocyte generation,
other organs are also of great significance for the immune system. These or-
gans include lymph nodes and the lymphoid follicles in tonsils, spleen, ade-
noids, skin and Peyer’s patches that are belonging to the mucosa-associated-
lymphoid-tissue (MALT). Populated by lymphocytes, plasma cells and macro-
phages, these tissues are ready to encounter antigens that pass through their
epithelia and can subsequently mount an immune response.
To generate an adaptive immune response, microbes need to be phago-
cytised by cells of the innate immune system. By transporting components
of the ingested material back to the surface, these phagocytes are able to
engage T-cells through piecewise presentation of antigens. Subsequent to
receptor-stimulation, activated lymphocytes expand clonally in order to in-
crease the number of receptor-specific leucocytes. These leucocytes are able
to recognize the currently threatening pathogen, and differentiate into ef-
fector cells. In the case of B-cells, encountering an antigen leads to the
differentiation into antibody-secreting plasma cells. The released antibodies
represent soluble lymphocyte-receptors, that constitute the humoral (from
latin hu¯mo¯ra¯lis; for moisture, bodily fluid) part of the adaptive immunity
in allusion to their site of action. The outcome of T-cell activation leads to
the establishment of cell-mediated immunity and engages the differentiation
of T-lymphocytes into specialized effector cells. In addition to the general
division of T-cells into the functionally different CD4pos and CD8pos T-cells,
antigen-stimulation leads to a further subdivision of the CD4pos T-cells. Ac-
cording to their cytokine profile, they can be classified either as TH1-cells
or TH2-cells. The production of interferon (IFN)-γ, tumour necrosis factor
(TNF)-β, interleukin (IL)-2 and other pro-inflammatory cytokines supports
the cell-mediated immunity and inflammation in TH1-weighted T-cells. In
contrast, TH2-cells produce — amongst others — IL-4, IL-5, IL10, and IL-
13 and thus provide help to B-cells and partially inhibit the functions of
phagocytic cells. The interaction of TH2-weighted T-cells with B-cells, and
the partial converse effects of TH1- or TH2-cytokines illustrate once more
the close dependency and interrelationship between the different immune
branches and the complexity of the immune system.
Altogether, the humoral and the cellular arm of the acquired immune
system represent a highly specific and flexible defence against different types
of infections. While antibodies function to eliminate extracellular pathogens,
activated T-cells combat intracellular microbes, together providing a global
protection at different sites of action.
Another unique feature of acquired immunity is the generation of a
long-term memory after first antigen-encounter. After a primary immune
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response against a newly recognized antigen has been mounted, a second
exposure to the same antigen will lead to a larger and more rapid immune
response. In contrast to primary immune responses, which are mediated
by immunological unexperienced T-cells (“na¨ıve” T-cells , Tna¨ıve) that have
not recognized their antigen yet, secondary immune responses are mounted
by cells that were induced during the first antigen encounter, (“memory”
T-cells, Tmem). In mice, surface expression of CD62L is indicative of Tna¨ıve,
whereas Tmem typically lack CD62L but express CD44.
The list of the main effectors in the adaptive immune system is completed
by regulatory T-cells (Treg). These CD4
pos T-cells are characterized by
their potential to modulate and abrogate immune responses after successful
elimination of invading organisms. As they also suppress the activation of
other T-cells, they are able to prevent pathological self-reactivity. Therefore,
Treg are often linked to the maintenance of tolerance against “self” and the
prevention of autoimmunity. Still, many open questions about Treg and their
mode of action remain unanswered. So far, the cell’s immuno-suppressive
potential is ascribed to the release of the anti-inflammatory cytokines IL-10
and tumour growth factor (TGF)β which in turn inhibit the activation of
TH1-and TH2-cells and the production of antibodies.
Characteristically, Treg express the transcription factor forkhead box
P3 (FoxP3) and the α-chain of the IL-2 receptor, namely CD25. IL-2 is
necessary for the growth, proliferation and differentiation of T-cells into the
effector T-cells mentioned above. Expressing the IL-2 receptor α-chain, Treg
are able to bind and internalize IL-2, which leads to the deprivation of IL-
2 for the effector T-cells. After elimination of the infection, the immune
response contracts and returns to a resting state, until another infection
needs to be combated.
In comparison to the immediacy of the innate immune system, the ac-
quired immune system only becomes fully active within several days. This
delay can be ascribed to the different immunological strategies applied by
both systems. In order to recognize any conceivable antigen, immune re-
ceptors of the adaptive immune system are highly divers. As a result, there
are only very few cells, recognizing a specific epitope. Therefore, antigen
encounter first leads to an extensive proliferation of the specific T- and
B-cells that have been activated. Typically, this cellular expansion takes
several days. During this time, the protection against infectious agents re-
lies on the innate immune system. In summary, the seamless collaboration
of both, the innate and the adaptive arm of the immune defence provide
us with a highly complex defensive system and supplies both instant pro-
tection against invading pathogens and long-termed immunity through the
generation of memory.
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1.2 Thymus
The thymus is a bilobed organ located in the central compartment of the
thoracic cavity, positioned behind the sternum and in front of the heart.
As a primary lymphoid organ, the thymus is the site for the formation and
maturation of functional T-cells (Miller, 1964). Because of their potent
functions in the defence against pathogens and transformed cells, mature T-
cells harbour also the potential to be harmful against the host. Indeed, their
antigen receptor rearranges randomly to facilitate the recognition of any po-
tential antigen. Hence, a reliable and careful selection of T-cells during their
development is essential. The thymic stromal micro-environment is respon-
sible for this selection. It guarantees that T-cells survive only if they have
successfully rearranged a receptor with the potential to react to foreign anti-
gens but have been rendered tolerant to self-peptides. The thymic stroma is
mainly composed of two types of thymic epithelial cells (TEC), which are in
close contact to developing thymocytes and which exert distinct functions
relevant for T-cell maturation: cortical thymic epithelial cells (cTEC) and
medullary TEC (mTEC). These functions include the attraction of T-cell
precursors from the blood, the subsequent maturation, selection, and even-
tually the export of functional T-cells. Importantly, the interactions of the
thymic epithelium with thymocytes are bidirectional. Data obtained from
mice with a block in T-cell maturation have shown, that an unperturbed T-
cell development is also a prerequisite for the establishment of a functional
thymic epithelium (Holla¨nder et al., 1995; Shakib et al., 2009).
The following subsections will provide a brief overview of the develop-
ment, anatomy and function of the thymus and characterize the complex
interplay between TEC and thymocytes in more detail.
1.2.1 Development
Initial phases of thymus development
The vertebrate thymus constitutes cells that originate from all three em-
bryonic germ layers; endoderm-derived epithelium, neuroectoderm-derived
neural crest cells, and mesoderm-derived haematopoietic cells and endothe-
lial cells (Smith, 1965; Moore and Owen, 1967; Owen and Ritter, 1969;
Le Douarin and Jotereau, 1975; Le Douarin et al., 1976). A unique aspect
of thymus development is the organization of the thymic epithelial cells. In
contrast to other epithelial organs, TEC do not form a sheet of cells posi-
tioned on a basement membrane (BM), but build a 3-dimesional network,
devoid of the BM scaffold. The initial formation of the thymic premordium
occurs at early stages of embryogenesis (E9.5 to E11.5) and involves inter-
actions between epithelial cells of the 3rd pharyngeal pouch (3pp) endoderm
and mesenchymal cells, derived from the neural crest (Cordier and Haumont,
1980; Manley, 2000). The process of thymic organogenesis can be divided
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into a sequence of several consecutive steps, starting with the initial posi-
tioning of the 3pp at embryonic day 9.5 (E9.5). Analysis of spontaneous and
gene targeted mutations have shown that this positioning depends on sev-
eral transcription factors, including T-box1 (Tbx1), homeobox A3 (Hoxa3)
(Manley and Capecchi, 1995; Chisaka and Capecchi, 1991), paired box gene
1 (Pax1) (Wallin et al., 1996), Pax9 (Peters et al., 1998; Hetzer-Egger et al.,
2002), eyes absent 1 homologue (Eya1) (Xu et al., 2002), and sine oculis-
related homeobox 1 homologue (Six1)6 (Xu et al., 2002). With the onset
of the expression of the glial cells missing homologue 2 (Gcm2) around E10
(Gordon et al., 2001), the patterning and outgrowth of the primordial is ini-
tiated (Nehls et al., 1994), leading to the generation of regional differences
within the cells of the growing rudiment. As a result two individual organs
evolve from the 3pp primordium. While cells of the dorsal part of the 3pp
develop into the parathyroid under the control of Gcm2, the ventral aspect
of the 3pp gives rise to the thymus anlage, a formation that is critically
dependent on the expression of the transcription factor Foxn1 (Nehls et al.,
1994). Foxn1 message can be detected in the 3pp derivates of embryos at
gestational day 10.5 using reverse transcription polymerase chain reaction
RT PCR, however high-level Foxn1 expression is only found after E11.25
(Gordon et al., 2001). Studies in nude mice, in which the Foxn1 gene is
mutated (Flanagan, 1966; Pantelouris, 1968), have shown that Foxn1 is not
required for the initial formation of the thymus rudiment. However, in the
absence of Foxn1, any further differentiation of the thymus anlage is blocked,
including its colonization with lymphocyte progenitors.
Entry of thymocyte progenitor cells and thymus patterning
The initial attraction of haematopoietic precursor cells to enter the thy-
mus primordium is initiated at E11.5 (Owen and Ritter, 1969). At this
time point, the thymus is not yet vascularized, and precursor attraction is
executed only by release of chemokines. In this context, chemokine (C-C
motif) ligand 25 (Ccl25), which is embryonally controlled by Foxn1, and
chemokine (C-C motif) ligand 21 (Ccl21) have been implicated in this pro-
cess (Bleul and Boehm, 2001). Analysis of mice which have a naturally
occurring deficiency for Ccl21 (plt/plt mice) or mice that lack Ccr9, the lig-
and for Ccl25 revealed a significantly lower number of thymocytes (Wurbel
et al., 2001; Liu et al., 2005) at the age of E14.5 or E17.5, respectively,
indicating the importance of these two chemokines in early thymic precur-
sor seeding. The experimental use of antibodies against Ccl21, Ccl25, and
(C-X-C motif) ligand 12 Cxcl12 to block their function confirmed the rel-
evance of Ccl21 and Ccl25 for early haematopoietic colonisation, whereas
neutralization of Cxcl12 did not result in an impaired thymocyte seeding
(Ara et al., 2003). Initial lymphoid colonisation occurs before significant
changes in TEC differentiation can be observed. This fact gave rise to the
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question whether thymocyte precursor may play any role in inducing devel-
opmental differentiation of the thymus stroma during this very early phase
of thymus organogenesis. To address this question, TEC differentiation was
analysed in recombination-activating gene 2/ common cytokine receptor γ-
chain-deficient (RAG 2/ γc) and Ikaros-null mice (Klug et al., 2002) — two
mutant mouse models that show a block in early lymphocyte differentiation.
Until E13.5, thymic development and TEC differentiation was unperturbed,
which led to the conclusion that despite of their early occurrence in the
thymus, initial patterning of the thymic epithelial compartment does not
depend on inductive signals from haematopoietic cells.
Late phases of thymus development; Thymocyte-TEC crosstalk
The later differentiation of TEC and the formation of the medullary com-
partment is highly dependent on “crosstalk” between thymic epithelium
and lymphoid cells (Ritter and Boyd, 1993; Nitta et al., 2011). Although
the precise mechanisms that regulate the initial and late-stage differenti-
ation of cortical and medullary TEC are still not fully understood, data
from mutant mouse studies imply the role of several factors for the estab-
lishment and maintenance of the epithelial compartment. Transgenic mice
that carry a mutant human CD3 ϵ chain, display a maturational block of
thymocytes at the CD44pos CD25pos stage (Holla¨nder et al., 1995). In these
mice, cortical epithelial cells fail to expand and organize normally. This
patterning defect can be reverted to normal thymopoiesis, once the mice are
reconstituted by normal bone marrow precursor cells. However, the rescue
fails and results only partially in a normal stromal compartment when the
reconstitution is attempted at adult stages. This finding led to the conclu-
sion that unperturbed epithelial differentiation and organization relies not
only on signals provided from developing thymocytes but also on a tem-
poral window of developmental opportunity. Though the cortical stroma
requires active crosstalk with thymocytes committed to the T-cell lineage
for its development (Naspetti et al., 1997; Wang et al., 1997), maturation
of the medulla depends on the presence of mature single positive (SP) α/β
or γ/δTCRhigh thymocytes. In mice deficient for ZAP-70 or TCR α, where
T-cell development is blocked prior to positive or negative selection, the
formation of the medulla is strongly impaired, resulting in a reduction of
medullary cells in the thymus (Surh et al., 1992; Naspetti et al., 1997). Even
though the mTEC compartment is hypocellular, the expression of markers
typically associated with mTEC differentiation is not altered (e.g. Autoim-
mune Regulator (AIRE) and tissue-restricted antigens genes). Thus, even in
the absence of signals from positively selected thymocytes, the expression of
functional molecules on mTEC is not affected (Hikosaka et al., 2008). The
medullary compartment is also contracted in a mouse model in which posi-
tively selected thymocytes are not able to migrate to the medulla following
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positive selection due to a lack of Ccr7 expression (Ueno et al., 2004). How-
ever, reduction in the number of mTEC is less severe in these mutant mice
when compared to that of the aforementioned ZAP-70 or TCR α knockout
mice. This finding strongly suggests that the defect in medulla formation is
rather linked to the lack of interactions with positively selected thymocytes
than a consequence of a general absence of thymocytes in the medulla. In
addition, numerous studies have revealed that signals mediated by members
of the TNFR superfamily, including lymphotoxin β (LTβ), receptor activa-
tor for NF-κB (RANK), and CD40, play an essential role in organizing the
medullary thymic epithelial cell compartment (White et al., 2010). In this
context, RANKL and its respective receptor on TEC has been identified as
potent mediator of thymic crosstalk, as its enforced expression was shown to
restore mTEC cellularity in mouse models with impaired positive selection
(Hikosaka et al., 2008). More recently, another cell type has been implicated
to play a role in mTEC development and differentiation, namely lymphoid
tissue inducer (LTi) cells. The appearance of these CD4posCD3neg cells in
situ was found to be temporally linked to the development of mTEC during
embryogenesis (Rossi et al., 2007). Indeed, RORγ-deficient mice, which lack
LTi cells, display a reduced number of specialized mTEC, marked by the ex-
pression of AIRE. This effect was causally linked to the lack of TEC-directed
RANKL signalling mediated by LTi cells.
Epithelial-mesenchymal interactions
Mesenchymal cells, initially derived from both the pharyngeal mesoderm
and the neural crest contribute to the outer thymic capsule (Le Lie`vre and
Le Douarin, 1975), the interlobular septae (Jiang et al., 2000), and the
intrathymic network of fibroblasts (Yamazaki et al., 2005), from as early
on as E11.5. A functional importance of neural crest-derived cells during
thymus development was suggested by experiments in which removal or
reduction of mesenchymal cells in the pharyngeal region resulted in either a
complete absence or a significant reduction of thymus cellularity (Bockman
and Kirby, 1984).
It is still not fully understood how mesenchymal cells support thymus
morphogenesis, but a possible molecular link between neural crest mes-
enchyme and epithelial cells is provided via fibroblast growth factors (FGF)
and their receptors (FGFR), respectively. Fgfr2-IIIb is expressed on TEC
as early as E13 (Revest et al., 2001), (Jenkinson et al., 2003), where it is
thought to interact to Fgf7 and Fgf10, which are produced by the surround-
ing mesenchyme (Revest et al., 2001). The evidence for the importance of
Fgfr2-IIIb results from studies of Fgfr2-IIIb -/- mice. After initially normal
thymus development, thymus growth is severely stunned in these mice from
E12.5 onwards (Revest et al., 2001). Other factors potentially involved in
the proliferation and differentiation of immature thymic epithelia include
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epidermal growth factor (EGF), insulin-like growth factors-1 (IGF 1) and
-2, retinoic acid (Shinohara and Honjo, 1996; Jenkinson et al., 2003; Bhasin
et al., 2004). Once epithelial cells have acquired the competence to fully
support T-cell development, and the establishment of thymic vasculature is
complete, the presence of neural crest-derived mesenchymal cells decreases
(Yamazaki et al., 2005; Jiang et al., 2000), and further TEC differentiation
becomes largely independent of ongoing mesenchymal support (Jenkinson
et al., 2007). The question whether these cells persist in the thymic mi-
croenvironment to time points beyond the newborn age remained open for
quite some time. Using genetic markers expressed under the promotor of
Wnt1 (Danielian et al., 1998) and Sox10 (Matsuoka et al., 2005) — which are
expressed in the neural plate from which neural crest-derived cells (NCCs)
originate (Echelard et al., 1994; Matsuoka et al., 2005) — it was then con-
vincingly demonstrated that NCCs constitute a major cellular component in
the adult thymus. These studies furthermore demonstrated that NCCs dif-
ferentiate into smooth muscle cells and perivascular cells (pericytes), which
are both involved in forming a supportive network for thymic blood ves-
sels. More recently, pericytes were identified as a source for sphingosine-1-
phosphate (S1P), which promotes the egress of mature thymocytes (Mat-
loubian et al., 2004).
1.2.2 Thymus anatomy and cellular characterization
The composition of the thymic stromal compartment is heterogenous and
comprises the aforementioned thymic epithelial cells (TEC), as well as en-
dothelium, fibroblasts, macrophages, dendritic cells (DCs) and other rare cell
types. TEC represent the most abundant cell population within the thymic
stroma. According to their location, function, and characteristics, they can
be further subdivided into cortical and medullary TEC. The anatomic re-
gion that is located at the border between cortical and medullary TEC
is defined as the cortico-medullary junction (CMJ). This region is highly
enriched for vessels that are surrounded by a perivascular space, which is
thought to be involved in T-cell progenitor immigration as well as in the
export of newly generated T-cells to the circulation (Mori et al., 2007).
The thymic cortex, which surrounds the medullary compartment, is com-
posed of a three-dimensional meshwork of reticular cTEC. These epithelia
are phenotypically best characterized by distinctive patterns of extracellu-
lar antigens (such as Ly51) and intercellular proteins (such as Keratin 8
(K8)) (Godfrey et al., 1988; Klug et al., 1998; Surh et al., 1992). mTEC
which similarly form a three-dimensional stromal network in the inner core
of the thymus are characterized by a reactivity with Ulex europaeus agglu-
tinin I (UEA1) and the expression of Keratin 5 (K5). A typical feature that
both epithelial cells subtypes share, and which is related to their function of
antigen-presentation to developing thymocytes, is the expression of major
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histocompatibility II (MHCII) molecules. Based on the amount of MHCII
expression, cTEC and mTEC are further subdivided into cells with a high
(MHCIIhigh) or low (MHCIIlow) expression. The quantity of MHCII ex-
pression per TEC follows a typical kinetic over time: MHCII expression on
TEC is typically low during embryonic stages and changes to a consistently
higher expression after birth. By two weeks of age, a significant population
of MHCIIlow TEC emerges in parallel to MHCIIhigh cells. This phenotype
correlates with other molecular markers of epithelial immaturity and is thus
used in mice three weeks and older to identify immature TEC in both cortex
and medulla. TEC with a low MHCII cell surface expression expand over
time and eventually become the predominant TEC subpopulation in older
mice (Gray et al., 2006). Among the MHCIIhigh mTEC, expression of the
Autoimmune Regulator (AIRE), which plays a crucial role in the induction
of T cell tolerance towards tissue-restricted antigens (Derbinski et al., 2001;
Anderson et al., 2002), can be used to further distinguish these cells into
distinct, terminally differentiated subpopulations (Hamazaki et al., 2007).
mTEC and cTEC are derived from a common progenitor (Bleul et al.,
2006; Rossi et al., 2006; Hamazaki et al., 2007; Shakib et al., 2009). However,
the individual steps of differentiation that finally result in the generation of
phenotypically and functionally cTEC or mTEC compartments remain still
not fully defined, not least because TEC differentiation is regulated by cell-
intrinsic factors and extrinsic factors, provided by the local environment
(reviewed in Rodewald (2008); Anderson et al. (2009)).
1.2.3 Thymic function
Random rearrangements of the genetic elements that encode the different
parts of the TCR are responsible for the great variability in TCR speci-
ficities generated during intrathymic T-cell development. The downside of
this mechanism is the danger of generating receptors that are either non-
functional in or harmful to the individual. In order to avoid propagation of
useless or self-reactive T-cells, developing thymocytes undergo several selec-
tion processes, during which only those cells survive which have successfully
rearranged and expressed a T-cell receptor that has specificity for self-MHC
molecules presenting foreign (i. e. non-self) antigens. These essential selec-
tion processes are effected by the thymic stromal compartment.
Thymocyte development
The generation of thymocytes is dependent on a continuing input of blood-
born hematopoietic precursor cells (Kadish and Basch, 1976; Lepault and
Weissman, 1981; Leuchars et al., 1973) as there are no residual thymocyte
progenitors present in the thymus. After seeding into the thymus at the
cortico-medullary junction, immature progenitor cells undergo further dif-
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Figure 1.1: Anatomical microenvironment in the adult thymus; The thymus is a bilobed
organ divided by mesenchymal septae. The two lobes are organized into discrete cortical and
medullary areas, each of which is characterized by the presence of particular stromal cell types,
as well as thymocyte precursors at defined maturational stages. Thymocyte differentiation can
be followed phenotypically by the expression of cell-surface markers, including CD4, CD8, CD44,
CD25, CD69 and CD62L, as well as the status of the T-cell receptor (TCR). Interactions between
thymocytes and thymic stromal cells are known to be important in driving a complex program of
T-cell maturation in the thymus, which ultimately results in the generation of self-tolerant CD4pos
helper and CD8pos cytotoxic T-cells, which emigrate from the thymus to establish the peripheral
T-cell pool. (TCRlow, expressing the TCR at low levels; TCRhi, expressing the TCR at high
levels.) Adopted from Graham Anderson and Eric J. Jenkinson; Lymphostromal interactions in
thymic development and function; Nature Reviews 2001
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ferentiation, which is marked by the loss of alternative lineage choices and
the commitment to the T-cell lineage. During the first steps of development,
the most immature thymocytes lack any expression of CD4, CD8 or CD3,
and are therefore referred to as double negatives (DN) thymocytes. They
undergo four distinct maturational stages, whereby each of them is charac-
terized by the differential expression of CD44 and CD25. The earliest DN
subpopulation is defined as DN1 (which includes also early thymic presur-
sors; ETPs, which are marked by the expression Sca1), and is identified by
the absence of CD25 and several lineage-associated markers (such as CD3,
CD4, CD8, CD11b, CD11c, CD19, B220, F4/80, Ter119, Gr1, Nk1.1, Dx5,
TCRα/β, TCRγ/δ) and expresses CD44 and high amounts of c-kit. These
early thymocytes still bear the potential to develop into T-cells, dentritic
cells (DC), macrophages and natural killer cells (NK), but lost their poten-
tial to differentiate to erythroid cells and megacaryoctes. In other words,
they have not yet fully committed to the T-cell lineage. During their mat-
uration, DN1 cells migrate from their site of entry, through the cortex in
direction of the subcapsular region. During this journey, they transiently at-
tain the DN2 phenotype (c-kithighCD44posCD25pos) and subsequently reach
the DN3 stage (c-kitlowCD44negCD25pos). At this stage, the recombinases
activating genes RAG1 and 2 are expressed and catalyze the successful re-
arrangement of the β, γ and δ loci. In contrast to α/β T-cells, γ/δ T cells
represent only a small subset of T-cells in the mature thymus. Further de-
velopment and survival of thymocytes depends on signals mediated by the
TCR. The TCR of DN3 thymocytes is composed of the rearranged β-chain,
an invariant pre-TCR α-chain (pTα) and the CD3 complex (composed of
four distinct chains; γ, δ, ϵ and ζ). Only successfully rearranged β-chains
can be incorporated into the complete and functionally competent pre-TCR
complex. The necessary signals required for survival and further develop-
mental maturation and proliferation then emanate from this receptor. This
event is referred to as β-selection and constitutes the first checkpoint in
thymocyte development. Following β-selection, the cells become committed
to the α/β lineage, start to rearrange the TCR α-chain, arrest the rear-
rangement of their β-chain, and attain the simultaneous expression of the
co-receptors CD4 and CD8. Cells in this developmental stage are known as
double positive (DP) cells and are now unresponsive to interleukin-7 (IL-7),
which plays a critical role during the previous T-cell developmental stages
(Fry and Mackall, 2005). These DP thymocytes represent the most abun-
dant subset within the thymus (80% to 90%). At this and the following
stages, thymocytes are subjected to distinct selection processes, leading to
the death of more than 90% of the DP population. (Fig. 1.1).
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Positive selection
In contrast to the TCR β chain, rearrangement of the TCR α locus is not
arrested after productive rearrangement of one TCR α-chain. To terminate
the TCR α locus rearrangement, a successful interaction of the TCR α/β
with major histocompatibility (MHC) molecules is required, which leads
to the selection of MHC-restricted TCRs (Borgulya et al., 1992; Bra¨ndle
et al., 1992). The structure of the α locus facilitates multiple V/J recom-
bination events on the same allele, resulting each time in the excision of
the prior recombined DNA. This set-up allows for the testing of multiple
TCR α gene rearrangements per cell, enhancing the production of useful
thymocytes by increasing the frequency of positively selectable TCR α/β
heterodimers (Petrie et al., 1993; Davodeau et al., 2001). However, the time
for rearranging and testing functional TCR α/β complexes is short, as DP
cells need to interact with MHC molecules within 3 to 4 days to receive the
necessary survival signals. Consequently, cells that are not able to assemble
a functionally competent MHC-restricted TCR will die by neglect.
There are two types of MHC molecules, termed MHC class I (MHCI)
or MHC class II (MHCII). Developing T-cells will need to bind to either
MHC class I or class II molecules to receive and transmit the aforemen-
tioned survival signal. In this process of TCR-mediated interaction of de-
veloping thymocytes with thymic stromal cells, the transmembrane proteins
CD4 and CD8 play a decisive role. Their extracellular domains CD4 and
CD8 are able to bind specifically to invariant determinants on MHC class II
and MHC class I molecules, respectively, while their intracellular domains
associate with the non-receptor protein tyrosine kinase Lck, which initiates
TCR signal transduction when enzymatically activated (Doyle and Stro-
minger, 1987; Norment et al., 1988; Shaw et al., 1989). As the co-receptors
and the TCR are thought to bind to the same peptide-MHC complex, intra-
cellular Lck is brought into close proximity with the cytosolic domains of the
invariant CD3 chains associated with the engaged TCR. This consequently
results in the initiation of signalling (Veillette et al., 1989b,a).
Positive selection is initiated in the cortex. This event is characterized by
a sustained low-affinity engagement of the TCR with the self-peptide-MHC
complex on the surface of cTEC. This interaction is only rarely successful, so
that the survival of DP cells occur in 5% of these cells (Wilkinson et al., 1995;
Starr et al., 2003). With positive selection, the decision to ultimately develop
into either CD4 or CD8 single positive (SP) T-cells is determined. By means
of TCR-transgenic mice, it was shown that CD4 or CD8 lineage commitment
is defined by the MHC-restriction specificity of the respective TCR. DP
thymocytes, which acquired a signal by MHCII-restricted TCRs differentiate
into CD4pos T-cells, whereas DP thymocytes that interacted via MHC-I-
restricted TCRs differentiate into CD8pos T-cells. However, down-regulation
of CD4 or CD8 occurs asynchronously (Barthlott et al., 1997; Singer et al.,
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Figure 1.2: Maturation steps of
late thymocytes; Developing thymo-
cytes differ in their surface expres-
sion of the CD4 and CD8 co-receptor.
Double negative (DN) cells differenti-
ate into double positive (CD4posCD8pos)
DP thymocytes, which are the first cells
to express a functional T-cell receptor
(TCR). DP that are able to interact
via their TCR with major histocompat-
ibility (MHC) molecules undergo posi-
tive selection and become CD4posCD8low
TCRint. Thymocytes that have encoun-
tered MHCI molecules will further differ-
entiate into CD8pos, cells that interacted
with MHCII molecules differentiate into
CD4pos mature thymocytes.
2008), resulting in a characteristic phenotype of developing SP according to
their expression of CD4 or CD8 as depicted in Fig. 1.2. Distinct subsequent
stages in the development of thymocytes can be identified using several cell
surface markers, such as CD24, which is highly expressed in DP thymocytes,
the early activation marker CD69, which gets rapidly induced after TCR
interaction, and the surface expression of the TCR itself. The successful
TCR-MHC-interaction also leads to the down regulation of RAG expression
— precluding any further alternate TCR α/β configurations. Finally, the
migration into the medulla occurs where the last steps in T-cell maturation
are accomplished.
Negative selection
Medullary TEC attract positively selected thymocytes via expression of the
chemokines Ccl21 and Ccl19, which are bound by Ccr7 on immature thymo-
cytes following the engagement of their TCR with Peptide-MHC complexes
expressed by cTEC (Ueno et al., 2004). The medulla is the primary site
for the next selectional screening of the chosen TCR specificities known as
negative selection. This process ensures that only thymocytes that express a
TCR that binds self-peptide-antigen complexes with a low affinity can con-
tinue their maturation whereas all others undergo either lineage deviation
(Derbinski et al., 2001) or apoptosis. To evaluate TCR affinity for self-
peptides, positively selected thymocytes are exposed to divers self-antigens
presented by mTEC and dendritic cells (DC). To achieve an almost com-
plete coverage of self-antigens, mTEC use a unique epigenetic mechanism,
termed promiscuous gene expression. This phenomenon is in part regu-
lated by the expression of the autoimmune regulator AIRE and results in
the low expression of genes, including so-called tissue-restricted self-antigens
(TRAs) (Derbinski et al., 2005). This expression facilitates the preemptive
elimination of T-cells that express potentially harmful TCR specificities.
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Remarkably, the same receptor that provided the survival signal for positive
selection decides also whether a cell gets negatively selected. The current
model explaining this apparent paradox is based on the assumption that the
affinity of the TCR for the peptide-MHC complexes defines the ultimate fate
of the T-cell (Palmer and Naeher, 2009). In this context, cells that express
intermediate affinity TCR and hence display autoreactivity evade negative
selection and subsequent deletions as these cells can develop into FoxP3pos
regulatory T-cells (Treg) (Picca et al., 2009; Klein and Jovanovic, 2011).
An impressive example for the importance of negative selection by self-
antigens is the observation that the absence of thymic expression of a single
retinal antigen is sufficient to trigger spontaneous eye-specific autoimmunity
(DeVoss et al., 2006).
Thymocyte egress
Thymocytes susceptible to undergo negative selection are typically marked
by the concomitant expression of the early activation markers CD69 and
CD24 (Kishimoto and Sprent, 1997). As soon as CD69 is downregulated,
engagement of the TCR results in the induction of proliferation identical
to that of Tna¨ıve cells. With the loss of CD69, the spingosine-1-phosphate
receptor 1 (S1P1) appears on the surface. This receptor binds spingosine-
1-phosphate (S1P). Using an intravascular procedure to label emigrating
cells, Zachariah et al. could demonstrate that mature thymocytes exit the
thymus via blood vessels at the corticomedullary junction and that neural
crest-derived pericytes, which typically ensheath blood vessels, are a main
source for S1P (Zachariah and Cyster, 2010). The significance of S1P1 in
thymocyte egress was demonstrated in mice whose haematopoietic cells ei-
ther lack S1P1, or in mice where a S1P1 transgene is constitutively expressed
by developing thymocytes (Matloubian et al., 2004; Zachariah and Cyster,
2010). S1P1-deficiency precludes the emigration of T-cells to the periph-
ery, whereas transgenic overexpression of S1P1 under the control of the Lck
proximal promotor lead to the precocious appearance of DP in blood, lymph
nodes and spleen. The molecular mechanisms that lead to the expression of
S1P1 are closely linked to the cessation of TCR signalling, which results in
the termination of Akt-mediated phosphorylation of the transcription fac-
tor forehead box O (FOXO). Unphosphorylated FOXO can translocate into
the nucleus, where it initiates kru¨ppel-like factor 2 (KLF2)-mediated S1P1
expression.
1.3 Immune system and Metabolism
The development of immunopathologies is often directly linked to defects
in genes encoding relevant components of the immune system (Maro´di and
16
Notarangelo, 2007). There are, however, exceptions, where immunodefi-
ciencies are caused by a defective factor that shows no obvious link to the
immune system. For example, the absence of the enzyme adenosine deami-
nase (ADA), which is part of the purine salvage pathway, is one of the causes
of a severe combined immunodeficiency disease (SCID). As ADA is involved
in the breakdown of adenosine from food and the turnover of nucleic acids
in cells, the deficiency of ADA results in the accumulation of purine metabo-
lites, such as deoxyadenosine and deoxyadenosine phosphate (dATP), which
induce the activation of an apoptotic cascade. Consequently, many cells fail
to develop properly and undergo programmed cell death. Although ADA is
expressed virtually in every cell, most of the effects caused by the lack of this
enzyme are focussed on the immune system. The selective involvement of
the immune system can be partly ascribed to the high rate of cell death fol-
lowing T-cell selection, which provides a constantly high intrathymic source
of DNA that needs to be degraded (Carson et al., 1977). Therefore, in
ADA-deficient patients the thymus is one of the primary organs affected,
compromising proper T-cell development and function. The causal relation
between ADA-deficiency and SCID was a completely unexpected finding and
provided first evidences for the relevance of a metabolic compound for the
function of the immune system.
Obviously, one can argue that cellular metabolism in general plays an
essential role for any cell, and it is clear that specialized cellular functions
are dependent on the availability of energy and/or the absence of toxic
substrates. However, evidence is nowadays accumulating that immune cells
may use metabolic pathways to control fate decisions and function in ways
that are different from other cells. This interplay between immunological
and metabolic processes is permanent, and in contrast to ADA-deficiency
completely independent of any genetic defects. In this context, the field of
the so-called ”immune metabolism” has emerged to dissect the molecular
mechanisms of the immunological-metabolic crosstalk.
It has been observed that obesity affects the immune system and pro-
motes inflammation (Lumeng et al., 2007; Ouchi et al., 2011). Investigation
of the involved mechanisms revealed that some molecules which are primar-
ily known for sensing and responding to cellular nutrients also control fate
switches of immune cells. mTOR is one of those metabolic sensors, that
turned out to play a crucial role in the development and function of immune
cells.
The following chapters address the link between mTOR and the organi-
zation and maintenance of a functional immune system.
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1.4 mTOR
The discovery of the mTOR pathway began in the 1970s with the isola-
tion of the macrolide antibiotic rapamycin from a soil sample taken from
Easter Island (in Polynesian: “Rapa Nui” or navel of the world) that con-
tained of the bacterium streptomyces hygroscopius. The role of rapamycin
as a potent immunosuppressant was established over many years (Sabatini
et al., 1994; Brown et al., 1994; Sabers et al., 1995) and included in 1991 the
identification of the drug’s substrate known as “mammalian (subsequently
mechanistic) target of Rapamycin” (mTOR) by M. Hall and colleagues at
the Biocentre Basel (Heitman et al., 1991). In the following years, rapamycin
and the mTOR controlled pathway have gained central attention especially
in the domains of oncology and immunology (Zhang et al., 2011; Gupta
et al., 2012).
The mTOR protein is an evolutionally highly conserved 289-kDa serine-
threonine kinase, which belongs to the phosphoinositide 3-kinase (PI3K)-
related kinase family. Structurally, it consists of multiple Huntingtin, Elongation
factor 3, Protein phosphatase 2EA, TOR1 (HEAT)-repeats at its N-terminal
half followed by the FKBP12-rapamycin-binding and serine-threonine pro-
tein kinase domains near its C-terminal end (Fig. 1.3). The kinase activity
is presently the only known enzymatic functions of mTOR. The mTOR pro-
tein forms two distinct multi-protein-complexes, termed mTOR complex 1
(mTORC1) and mTORC2. They differ in their upstream regulators, their
downstream targets and the biological processes they control (Laplante and
Sabatini, 2009).
1.4.1 mTORC1 - structure and components
mTORC1 consists of five proteins, with mTOR serving as the catalytic
subunit of the complex. Two of the five proteins are unique for mTORC1,
namely the regulatory-associated protein of mammalian target of rapamycin
(raptor) (Hara et al., 2002; Kim et al., 2002) and proline-rich Akt substrate
40 kDa (PRAS40) (Sancak et al., 2007; Wang et al., 2007; Vander Haar
et al., 2007), whereas mTOR itself and three additional proteins are also
components of mTORC2.
Raptor is a 150 kDa protein that contains a conserved region in its
N-terminal half, three HEAT repeats and seven WD-40 repeats (charac-
terized by two terminal amino acids Tryptophan and Aspartic acid) near
the C-terminus. Both, HEAT- and WD-40 repeats form curlicue-like struc-
tures that serve either as flexible (HEAT), or as rigid scaffold (WD 40) on
which proteins bind and interact. Due to its structure, raptor has been
thought to function as an adaptor molecule, regulating mTORC1 activity
by recruiting substrates. The association of raptor to mTOR is sensitive
to the presence of rapamycin and the nutritional status (Kim et al., 2002).
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Figure 1.3: mTOR components; Scheme of mTORC1 and mTORC2 binding partners. In
yellow: proteins unique for mTORC1, in blue: mTORC2-specific protein, in green: elements
of both mTOR complexes. The following abbreviations were used: Pras40: proline-rich
Akt substrate 40 kDa; Raptor: regulatory-associated protein of mammalian target of rapamycin;
Deptor: DEP domain containing mTOR-interacting protein; mLST8: mammalian lethal with
sec-13 protein 8; mSIN1: mamalian stress-activated protein kinase (SAPK)-interacting protein
1; Rictor: rapamycin insensitive companion of mTOR; Protor 1/2: protein observed with Rictor
1/2; HEAT repeats: Huntingtin, Elongation factor 3, Protein phosphatase 2 EA, TOR1 repeats;
FAT domain: FRAP-ATM-TTRAP domain; FRB domain: FKBP12-rapamycin binding domain;
FATC domain: FAT-C-terminal domain; Adapted from Laplante and Sabatini, Cell 2012
Raptor can be phosphorylated at multiple sites, by mTOR itself (Wang
et al., 2009; Foster et al., 2010), the ribosomal S6 kinase (Rsk1/2) (Carrie`re
et al., 2008; Roux et al., 2004), or the extracellular-signal-regulated kinase
(ERK) (Foster et al., 2010; Langlais et al., 2011; Carriere et al., 2011), which
typically enhances mTORC1 activity. During mitosis, raptor is hyperphos-
phorylated (Ramı´rez-Valle et al., 2010), promoting mRNA translation by
internal ribosome entry sites (IRES). This hyperphosphorylation is blocked
by inhibitors of the cell division control protein 2 homolog (Cdc2) or glyco-
gen sy thas kinase (GSK3) pathways. Other factors that negatively reg-
ulate mTORC1 signalling via modification of raptor are 5’ AMP-activated
protein kinase (AMPK) (Gwinn et al., 2008), and the autophagy associ-
ated Serine/threonine-protein kinase ULK1 (Dunlop et al., 2011). These
examples show that mTORC1 activity can be modulated by several path-
ways, which all involve phosphorylation of raptor. Similar to the ablation
of mTOR, the knockout of raptor is embryonic lethal (Guertin et al., 2006).
PRAS40 is a crucial mediator of Akt signalling towards mTOR (Van-
der Haar et al., 2007). PRAS40 interaction with mTOR is induced under
conditions that inhibit mTOR signalling, such as nutrient or serum depri-
vation or mitochondrial metabolic inhibition (Vander Haar et al., 2007).
PRAS40 binds the mTORC1 via raptor and regulates mTORC1 activity by
functioning as a direct inhibitor of substrate binding. Following Akt activa-
tion by Insulin, PRAS40 is phosphorylated at Thr 246 which results in its
dissociation from mTORC1 and the relieve of its constraints on mTORC1
activity (Sancak et al., 2007; Vander Haar et al., 2007). The components
that are shared by mTORC1 and mTORC2 are mammalian lethal with sec-
13 protein 8 (mLST8, also known as GβL) (Jacinto et al., 2004; Kim et al.,
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2003), DEP domain containing mTOR-interacting protein (DEPTOR) (Pe-
terson et al., 2009), and the Tti1/Tel2 complex (Kaizuka et al., 2010). Anal-
ysis of mLST8 domain organization has revealed that it consists of seven WD
domains which form a β propeller. This structure is typically related to
protein-protein interactions. Indeed, studies in mLST8 knockout mice have
provided evidence that mLST8 is required to maintain the Rictor-mTOR
interaction, but is dispensable for raptor-mTOR interaction (Guertin et al.,
2006). The exact function of the other mTOR-interacting proteins is still
not well defined and requires further investigations.
Upstream regulators of mTORC1
mTORC1 integrates a variety of upstream signals in order to coordinate the
metabolic switches from a catabol to an anabol status and vice versa as
a consequence of the respective nutritional conditions. To react to chang-
ing metabolic states, mTORC1 is receptive to divers intra- and extracellu-
lar cues, such as levels of growth factors, energy, oxygen, and amino acids
(Fig. 1.4). The high number of upstream regulators provides diverse infor-
mation input about the local and global energy availability in the organ-
ism. Based on these environmental leads, mTORC1 initiates central an-
abol metabolic processes including ribosomal biogenesis, initiation of trans-
lation or lipid synthesis whilst inhibiting at the same time catabol activi-
ties, such as autophagy. One of the key upstream regulators of mTORC1
is the heterodimer tuberous sclerosis 1 (TSC1, also known as harmatin)
and TSC2 (also known as tuberin) which functions as GTPase-activating
proteins (GAP) for the Ras homolog enriched in brain (Rheb) GTPase.
When bound to GTP, Rheb positively regulates mTORC1 by stimulating
its kinase activity (Long et al., 2005). However, functioning as GTPase,
TSC1/TSC2 can convert Rheb into its inactive GDP-bound state, thus in-
hibiting mTORC1 activity (Inoki et al., 2003b).
Most of the mTORC1 upstream signals act on TSC1/TSC2, which conse-
quently either inhibits or enables mTORC1 activity. Growth factors, such as
Insulin and Insulin-like growth factor 1 (IGF1) induce the phosphorylation
of TSC1 and TSC2 via activation of the PI3K and Ras controlled pathways
and the subsequent release of effector kinases (e. g. kinase B (Akt/PKB),
extracellular-signal-regulated kinase 1/2 (ERK1/2), and ribosomal S6 kinase
(RSK1)). Phosphorylation of TSC1/TSC2 abrogates its capacity to inhibit
mTOR (Inoki et al., 2002; Roux et al., 2004; Jaeschke et al., 2002). In a sim-
ilar way, proinflammatory cytokines, e.g. tumor necrosis factor α (TNFα),
initiate the phosphorylation of TSC1 and therefore trigger the inactivation
of the TSC1/TSC2 complex (Lee et al., 2007). Stimulation of Akt acti-
vates mTORC1 through interaction with the TSC1/TSC2 complex and the
mTORC1 inhibitor PRAS40 (Wang et al., 2007; Sancak et al., 2007; Van-
der Haar et al., 2007; Thedieck et al., 2007). Finally, also signalling via the
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Figure 1.4: The mTOR Signalling Pathway; The main signalling nodes that regulate
mTORC1 (on the right) and mTORC2 (on the left). Essential inputs regulating mTOR- sig-
nalling include amino acids, growth factors, energy, and oxygen. Active mTORC1 promotes pro-
tein synthesis, lipogenesis, and energy metabolism, whereas it inhibits autophagy and lysosome
biogenesis. In contrast, mTORC2 is activated by growth factors and regulates actin organization
and cell survival/metabolism. In this figure, environmental leads are depicted in violet, and the
main downstream effects of mTOR signalling in green. The following abbreviations are used:
Grb2: growth factor receptor-bound protein, SOS: son of sevenless, Ras: RAt Sarcoma, IRS: in-
sulin receptor substrate, phosphoinositide 3-kinase, GDP: guanosin disphosphate; GTP: guanosin
triphosphate, PIP2: phosphatidylinositol (4,5)-biphosphate PIP3: phosphatidylinositol (3,4,5)-
triphosphate, PTEN: phosphatase and tensin homologue, Raf: rapidly accelerated Fibrosarcoma,
Mek: mitogen-activated protein kinase kinase, Erk: extracellular signal-regulated kinases, GSK3β:
glycogen synthase kinase 3β, TSC1/2: tuberous sclerosis complex 1/2, Rheb: Ras homolog en-
riched in brain, AMPK: AMP-activated protein kinase, Pras40: proline-rich Akt/PKB substrate
40kDa, PDK1: phosphoinositide-dependent kinase 1, SGK1: serum/glucocorticoid regulated ki-
nase 1, PKCα: protein kinase Cα, FoxO: forkhead box O, S6K: ribosomal S6 kinase, 4EBP:
4E-binding protein, Hif1α: Hypoxia-inducible factor 1-α. Adapted from Laplante and Sabatini,
Cell 2012
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canonical Wnt pathway activates mTORC1 via inhibition of the glycogen
synthase kinase 3β (GSKβ), which usually promotes TSC2-activity (Inoki
et al., 2006).
The availability of energy to a cell is gauged by the level of Adenosine-
monophosphate-activated protein kinase (AMPK) activity. Low energy lev-
els or hypoxia activate AMPK by increasing intracellular AMP/ATP levels
(Hardie et al., 1998). AMPK can directly phosphorylate TSC in a way
that enhances its GAP activity towards Rheb and inhibits mTORC1 (Inoki
et al., 2003a). AMPK also communicates directly with mTORC1 through
phosphorylation of raptor, leading to the allosteric inhibition of mTORC1
(Gwinn et al., 2008).
The presence of amino acids — amongst them in particular leucin and
arginin — play a very decisive role in the activation of mTORC1 signalling.
Indeed, mTORC1 is activated by amino acids, which are a prerequisite for
the responsiveness to any upstream signal (Blommaart et al., 1995; Hara
et al., 1998).
The mechanism which guarantees that mTORC1 is only activated in the
presence of amino acids, depends on TSC1/TSC2 and requires Rag GT-
Pases, which are members of the Ras-family of GTP-binding proteins (Kim
et al., 2008; Sancak et al., 2008) and a multisubunit complex, called Ragu-
lator (Sancak et al., 2010). Mammals express four Rag proteins — RagA,
RagB, RagC, and RagD — that form heterodimers consisting of RagA or
RagB with RagC or RagD. RagA and RagB, like RagC and RagD, are
highly similar to each other and are functionally redundant (Schu¨rmann
et al., 1995; Hirose et al., 1998; Sekiguchi et al., 2001). Under amino acid-
rich conditions, RagA and RagB form GTP-loaded heterodimers, which are
able to interact with raptor. This interaction results in the translocation
of mTORC1 from a yet not well-defined position within the cytoplasm to
the lysosomal surface, where the complete complex is then activated. A
current model explaining the correlation between mTORC1 translocation
and activation indicates that mTORC1 binds to and interacts with lyso-
somal membrane-bound Rheb (Sancak et al., 2010). However, it remains
unknown why mTORC1 translocates specifically to lysosomes, since Rheb
is also found on other endomembranes.
Downstream effects of mTORC1
mTORC1 is a positive regulator of cellular proliferation and growth as it
promotes various anabolic processes that result in the biogenesis of proteins,
lipids and organelles but at the same time limits catabolic processes.
The best described mTORC1 targets are the eukaryotic initiation factor
4E (eIF4E)-binding protein 1 (4E-BP1) and the p70 ribosomal S6 kinase
1 (S6K1) (Ma and Blenis, 2009). Both are involved in protein synthe-
sis. Through phosphorylation of 4E-BP1, mTORC1 prevents its binding
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to the cap-binding protein elongation factor 4E (elF4E). Unbound elF4E
associates with elF4G to form the elF4E complex, which in turn is required
for the initiation of cap-dependent translation (Hay and Sonenberg, 2004).
Phosphorylated S6K also acts on the formation of the translation initiation
complex by phosphorylating eIF4B and the ribosomal protein S6 (Raught
et al., 2004), resulting in increased mRNA biogenesis and translational ini-
tiation and elongation. Raptor plays an important role for the interactions
of mTORC1 with S6K and 4E-BP1, as it mediates via a so-called TOR sig-
nalling (TOS) motif the efficient and specific binding to a conserved 5 amino
acid sequence in the N-terminal region of S6K and the C-terminal region of
4E-BP1(Nojima et al., 2003).
mTORC1 is also involved in the synthesis of lipids (reviewed in Laplante
and Sabatini (2009)). For example, mTORC1 positively regulates the activ-
ity of the two transcription factors sterol regulatory elementbinding protein
1 (SREBP1) (Porstmann et al., 2009) and peroxisome proliferator-activated
receptor-γ (PPARγ), which control the expression of factors that play a ma-
jor role in the homeostasis of lipids and cholesterol (Kim and Chen, 2004).
Mitochondrial gene expression and oxygen consumption are also regu-
lated by mTORC1 via (i) the transcriptional activity of the nuclear cofactor
PPARγ coactivator 1(PGC1-α) and (ii) the association with the transcrip-
tion factor yin-yang 1 (YY1) (Cunningham et al., 2007).
mTORC1 also inhibits autophagy to promote growth via the phospho-
rylation and hence suppression of ULK1/Atg13/FIP200 complex (unc-51-
like kinase 1/mammalian autophagy- related gene 13/focal adhesion kinase
family-interacting protein of 200 kDa) (Ganley et al., 2009; Hosokawa et al.,
2009; Jung et al., 2009).
Moreover, mTORC1 negatively regulates the formation of lysosomes,
which further contributes to the impairment of autophagy as their fusion
to autophagosomes is hindered. This inhibition is effected via phosphory-
lation of the transcription factor EB (TFEB), which is then prevented to
translocate to the nucleus and to control transcription of key factors in lyso-
somal function (Settembre et al., 2012). Furthermore, the use of quantitative
phosphoproteomics revealed that mTORC1 stimulates de novo synthesis of
pyrimidines and the progression through the S phase of cell cycle (Robitaille
et al., 2013).
Together, these findings underscore the significance of mTORC1 sig-
nalling, as it controls a remarkably high number of major cellular processes.
1.4.2 mTORC2 — structure and components
The mTORC2 pathway is in contrast to mTORC1 less well described. Ini-
tially it was thought that mTORC2 was insensitive to exposure to ra-
pamycin, as acute treatment with the macrolid failed to perturb mTORC2
signalling. However, long term exposure to rapamycin reduces nonetheless
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mTORC2 signalling in some cell types via the suppression of its assembly
(Sarbassov et al., 2006), though it still remains unclear why this longterm
effect is cell type specific.
As already mentioned, mTORC1 and mTORC2 share mTOR, mLST8,
DEPTOR and the Tti1/Tel2 complex (Fig. 1.3). The complex’s unique
components are the rapamycin insensitive companion of mTOR (rictor)
(Sarbassov et al., 2004; Jacinto et al., 2004), mammalian stress-activated
map-kinase interacting protein 1 (mSin1) (Jacinto et al., 2006; Frias et al.,
2006) and protein observed with rictor 1 and 2 (protor 1 and 2) (Thedieck
et al., 2007; Pearce et al., 2011).
Rictor has the ability to physically interact with the two other mTORC2-
specific components, mSin 1 and Protor 1, to form a stable structure (Jacinto
et al., 2006). Rictor lacks known common motifs but contains a C-terminus
that is conserved among vertebrates. Functionally, rictor may act as a scaf-
fold protein to mediate integrin-linked kinase activities (McDonald et al.,
2008). The rictor-mTOR complex directly phosphorylates Akt/PKB on Ser
473 in vitro and facilitates Thr 308 phosphorylation by PDK1(Sarbassov
et al., 2004). Furthermore, insulin signalling to FoxO requires rictor and
mLST8 (Guertin et al., 2006). Via the mTORC1/S6K1-dependent phos-
phorylation of rictor at threonine 1135, mTORC2 and Akt signalling can be
inhibited (Julien et al., 2010).
mSin1 contains a Ras binding domain (RBD), and a pleckstrin homol-
ogy (PH) domain that is likely to interact with phospholipids. It functions
as a scaffold protein, which regulates the assembly of mTORC2 and its in-
teraction with the serum/glucocorticoid-induced protein kinase 1 (SGK 1),
which is a key regulator of ion and solute transport processes in mammalian
epithelia (Lu et al., 2011). Similarly, protor 1 also increases the mTORC2
mediated activation of SGK 1 (Pearce et al., 2007).
Together, Rictor and mSin1 are responsible for the integrity of mTORC2
and play a key role in Akt phosphorylation and signalling (Jacinto et al.,
2006; Frias et al., 2006; Guertin et al., 2006).
Upstream regulators of mTORC2
Several regulators have been identified that are positioned upstream of
mTORC2 and control its activity (Fig. 1.4). mTORC2 is activated by
growth factors such as insulin, but is insensitive to amino acids. Acti-
vated mTORC2 binds to ribosomes in a fashion that is promoted by insulin-
stimulated PI3K signalling (Zinzalla et al., 2011). Since ribosomal biogenesis
is regulated by mTORC1, both mTOR complexes cooperate in the context
of protein synthesis.
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Downstream effects of mTORC2
mTORC2 controls cell survival, metabolism and cytoskeletal organization
by phosphorylation of protein kinases belonging to the protein kinase A, C
and G families (summarized as ACG kinases), including Akt, SGK1, and
the protein kinase C α (PKCα) (Yan et al., 2008; Zoncu et al., 2011). Akt is
a vital controller of survival, apoptosis, proliferation and growth through its
capacity to phosphorylate divers targets. To be completely activated, Akt
requires the phosphorylation of its Thr308, mediated by PDK1 and Ser473
by mTORC2. However ablation of several mTORC2 components showed
that lack of Akt phosphorylation at Ser473 did not impair the phosphory-
lation of several Akt targets, such as TSC2 and Glykogen synthase kinase
3 β (GSK3β), suggesting that defective Ser473 phosphorylation determines
rather the specificity of Akt than its activity (Guertin et al., 2006; Jacinto
et al., 2006). The only target affected by Akt bearing an impaired Ser473
phosphorylation was the forkhead box O1/3a (FoxO1/3a), a transcription
factor that is negatively regulated by this kinase. FoxO1/3a controls in a
tissue-dependent manner various target genes involved in metabolism, cell
cycle arrest, apoptosis and cell death.
SGK1 is another downstream target of mTORC2 important for the ac-
tivation of ion channels (Alessi et al., 2009), and is implicated in cancer cell
growth and survival (Dehner et al., 2008; Yan et al., 2008). SGK 1 shows
overlap in substrate specificities with Akt.
Selective deletion of mTORC2 elements in cultured cells also revealed its
involvement in actin cytoskeleton organization, through impaired activation
of PKCα and Rho-GTPases (Sarbassov et al., 2004; Jacinto et al., 2004).
Thus, actin polymerization and cell spreading are disturbed following the
inhibition of mTORC2.
1.4.3 The role of mTOR in the Immunesystem
mTOR regulates immune cell proliferation
In medicine, mTOR has first gained attention as a target for immuno-
supression, since its allosteric inhibition through rapamycin was found to
decrease IgE production and to protect against experimental autoimmune
encephalitis and adjuvant arthritis (Martel et al., 1977). However, ra-
pamycin only received serious consideration as an immunosuppressive drug
years later, when its ability to efficiently prevent T- and B-cell prolifera-
tion was discovered (Kay et al., 1991). Similar to the structurally related
macrolid FK506, rapamycin forms a complex with FK506 binding protein
(FKBP12), an immunophilin, and thus exerts its immunosuppressive po-
tential. Whereas FK506 modulates immune responses via the inhibition
of calcineurin-induced IL-2 production, rapamycin-FKBP12 interferes with
the IL2-stimulated activation of mTOR. Consequently, cell cycle progres-
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sion of T-cells is blocked at the transition from G1 to S phase precluding
the biological effect of IL-2. (Kuo et al., 1992; Abraham, 1998).
mTOR influences immune function
mTOR plays a critical role as a regulator of immune function and in T-cell
differentiation, because of its ability to sense and integrate cues from the
immune environment, such as the presence of IL-2, PD-1, CTL-4 or skewing
cytokines (reviewed in Delgoffe and Powell (2009)). The differentiation of T-
and B-cells into specialized effector and memory cells each requires specific
metabolic conditions in keeping with the individual lymphocyte functions
expected to be exercised. Thus, it is conducive to have a mechanism in place
that senses the availability of nutrients and immune-costimulatory molecules
to direct lymphocyte’s fate.
Under physiological conditions, the presence of nutrients, energy and
oxygen direct T-cell differentiation via facilitating mTOR signalling (Frauwirth
and Thompson, 2004). Naive T-cells reside typically in a catabolic state
with low levels of mTOR activity. Upon TCR activation, their metabolism
is switched from a cata- to anabolic state to meet the high metabolic re-
quirements of an effector T-cell. This switch is controlled by active mTOR,
and is a prerequisite for correct T-cell differentiation.
Indeed, studies in mice with T-cell-specific deletions of the central mTOR
complex components have revealed the importance of this complex in the
regulation of T helper cell differentiation. For example, T-cells lacking the
expression of the mTOR activator Rheb are not able to differentiate into
Th1 or Th17 cells under polarizing conditions (Delgoffe et al., 2011). This
failure is closely linked to a decrease in signal transducer and activator of
transcription (STAT) 3 and STAT 4 activation as well as in the expression of
the lineage-specific transcriptions factors T-bet (for Th1 cells) and RORγt
(for Th17 cells). In contrast, studies on T-cells lacking mTORC2 signalling
secondary to the ablation of rictor revealed a limited Protein kinase C 3
(PKC 3) activity as well as a reduced Trans-acting T-cell-specific transcrip-
tion factor 3 (GATA-3) expression, which rendered the cells incapable of
differentiating into Th2 cells under appropriate polarizing conditions (Del-
goffe et al., 2011; Lee et al., 2010). Finally, T-cell-specific inhibition of
both mTORC1 and mTORC2 increases SMAD3 following T-cell stimula-
tion, leading to the upregulation of the transcription factor FoxP3 and sub-
sequently to the generation of regulatory T-cells.(Delgoffe et al., 2011; Sauer
et al., 2008; Merkenschlager and von Boehmer, 2010; Haxhinasto et al., 2008;
Delgoffe et al., 2009). Moreover, the absence of mTOR promotes the differ-
entiation of CD8 pos memory T-cells (Araki et al., 2009). Finally, mTORC1
regulates cell migration by suppressing the synthesis of both chemokines and
cell-adhesion molecules, such as Ccr7 and CD62L (Sinclair et al., 2008), and
by promoting the effector function of CD8pos T-cells by in turn facilitat-
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ing the expression of the pro-inflammatory cytokine receptor C-X-C motif
receptor 3 (CXCR3) (Rao et al., 2010).
In summary, these data do not only underscore the general importance
of mTOR in directing T-cell fate but also reflect the individual impact of
mTORC1 and mTORC2 on the immune system.
In addition to its impact on T-cells, mTOR also influences B-cell dif-
ferentiation and function. In mTOR hypomorph mice (Zhang et al., 2011),
a partial block in the transition of large pre-B to small pre-B-cell stages is
manifest. For cells that reached the periphery, however, an increased fre-
quency in mature B cells and a concomitant decrease in transitional and
marginal zone cells was observed.
mTOR is also involved in the cellular maturation and homeostasis of
dendritic cells (DC) via engagement of Flt3-singaling (Sathaliyawala et al.,
2010).
Finally, mTOR signalling has also been associated with the regulation of
the innate immune response. Rapamycin-mediated mTOR inhibition pro-
motes the release of pro-inflammatory cytokines, such as IL-12, IL-23, and
IL6 in phagocytes following bacterial infection or exposure to lipopolysaccha-
ride (LPS) and leads to reduced synthesis of IL-10 and other anti-inflammatory
cytokines (Weichhart et al., 2008). In contrast, functional mTOR signalling
limits the production of pro-inflammatory cytokines by inhibition of nuclear
factor κ B (NFκB), whereas IL-10 production is promoted via the activation
of STAT3.
Although the significance of the mTOR pathway has been well charac-
terized for primary immune cells of the innate and the adaptive immune
system, like phagocytes, T-cells, B-cells or dendritic cells, no study has fo-
cussed yet on the role of the mTOR pathway for the function of a primary
lymphoid organ, such as the thymus.
1.5 Aim of the study
The mTOR pathway has gained increasing importance in biology and medi-
cine since its discovery in the 1980s. Being target of the macrolid antibiotic
rapamycin, its significance for the immune system became evident already
very early. Initially, mTOR’s immun-modulating properties have been as-
cribed to the fact that mTOR functions as a key regulator of cellular prolifer-
ation — and thus immune cell proliferation —, but later it became apparent
that mTOR is involved in a much broader context in the physiology of every
cell. Functioning as a link between metabolic demands and cellular func-
tion, mTOR senses environmental cues, and regulates cellular differentiation
and homeostasis. However, most studies performed so far focussed on the
role of the mTOR pathway or its inhibition in primary immune cells. To
extend this focus to cells which are not of lymphoid origin themselves but
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responsible for the maturation of competent immune cells, I investigated the
immunological role of mTOR for the thymic epithelium. This study seeks
to determine mTOR’s relevance for the development and maintenance of
TEC and to interrogate its influence on the distinct functions of cTEC and
mTEC during precursor attraction and thymocyte selection and maturation.
Through the generation of mice that are deficient for selective components
of the mTOR pathway in the thymic epithelium, it has been possible to
analyse the direct consequences of mTOR inhibition on the thymic epithe-
lium as well as the indirect effects on the development and maturation of
functional T-cells.
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Chapter 2
Materials and Methods
2.1 Mouse model and manipulations
2.1.1 Mice
Mice homozygous for LoxP-sites flanking either Raptor exon 6 (Raptorlox/lox),
Rictor exon 4 and 5 (Rictorlox/lox), or Raptor and Rictor (Raptorlox/lox
Rictorlox/lox) have been bred to transgenic mice expressing Cre recombinase
under the control of Foxn1 regulatory elements as described in the sections
3.1 -3.1.3 . Unless otherwise noted, mice were used between 4 and 15 weeks
of age. To define embryonic age, the day of the vaginal plug was designated
as E0. Mice were housed at the Center for Biomedicines animal facility
and at RCC Laboratory Animal Service, Fu¨llinsdorf. Mice were kept and
handled according to cantonal and federal regulations and permissions.
2.1.2 Time mating
For timed pregnancies one male and two females were separated in the same
cage for 2 days using a grid to prevent uncontrolled mating. After 48h the
grid was removed at 17h00. After 15h males were separated and females
were checked for vaginal plugs. Plug positive females were assumed to be at
gestational age 0 days.
2.1.3 Genotyping
Isolation of DNA
For isolation of genomic DNA, biopsies were digested in 500ml lysis buffer
supplemented with Proteinase K (confinal): 100µg/ml) and incubated for
at least 2 hours at 55C◦.
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Reaction Mix
Per reaction the following mix was used:
10ng DNA
2.5 µl 10X buffer (Sigma-Aldrich)
0.5 µl Primer (fw) at 5 µM
0.5 µl Primer (rv) at 5 µM
2.5 µl dNTPs at 10 µM (Sigma-Aldrich)
0.1 µl Taq Polymerase (5 U/µl) (Sigma-Aldrich)
add H2O to 25 µl (5 Prime)
Primer
The following primer pairs were used on genomic DNA:
Foxn1Cre:
(fw) TCTGATGAAGTCAGGAAGAACC;
(rv) GAGATGTCCTTCACTCTGATTC
Raptor deletion on gDNA:
(fw) ATGGTAGCAGGCACACTCTTCATG;
(rv) CTCAGAGAACTGCAGTGCTGAAGG
Primer used for qPCR are listed in section 2.5.2.
Cycle conditions for PCR amplification
PCR amplification was performed on Mastercycler (Eppendorf)
94◦C 5 min initially, followed by 33 cycles of:
94◦C 30 s
58◦C 45 s
72◦C 1 min
72◦C 10 min
hold at 12◦C
Agarose gel electrophoresis
10µl of PCR product were mixed with 1µl of loading dye including RedSafe
(Biotium) and loaded on a 2% agarose gel, prepared with TAE buffer to run
for 30 min at 75V. 2µl of a ready-load 1Kb plus DNA ladder (Invitrogen)
was used as a standard to determine the size of the PCR product. Pictures
were captured on Gel Doc XR (bioRad) and analysed with Quality One
4.6.2 software from Bio-Rad.
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2.2 Reagents
2.2.1 Buffer/Media
PBS sterile
Mili-Q Water + Dulbeco’s phosphate buffered saline powder (Sigma) with-
out CaCl2 and MgCl2. Filter sterilized (0.22µm cellulose acetate, bottle top
filtered, Coroning, NY, USA)
HBSS
500 ml (Gibco-BRL) without CaCl2 and MgCl2
FACS buffer
PBS (Sigma-Aldrich) +2% FCS (Perbio)
IMDM medium
IMDM (Gibco-BRL, Gaithersburg, USA) + 10% FCS (Perbio) + 0.5 ml β
Mercaptoethanol (50MM, Gibco-BRL) + 5 ml Kanamycin sulfate (Gibco-
BRL)
Digest solution
FACS buffer + Collagenase/Dispase (of 1mg/ml confinal; Roche Diagnos-
tics) + DNasae (20 µg/ml confinal; Roche).
Tail lysis buffer
10 ml 1M Tris pH 8.5 (100 mM confinal)
1 ml 0.5M Na EDTA (5 mM confinal)
1 ml 20% SDS (0.2% confinal)
4 ml 5M NaCl (200 mM confinal)
add 100 ml H2O
6x Loading buffer
0.25% Bromophenol blue (Fluka, Buchs, Switzerland)
0.25% Xylene cynol FF (Fluka)
15% Ficoll (Type 400; Sigma)
add 50 ml ddH2O
DNA ladder
Ready-load 1Kb Plus DNA ladder (Invitrogen)
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50x TAE
242 g Trizmabase (Sigma)
57.1 ml Glacial Acetic Acid (Fluka)
100 ml EDTA (0.5 M, pH 8.0; Sigma)
add ddH2O up to 1 l
2.2.2 Antibodies used for flow cytometry
Antibodies used for immunohistochemistry are listed in section 2.4.6. The
following antibodies were used for flow cytometric detection of intra- and
extracellular antigens:
FITC: CD24 (M1/69; BioLegend), CD25 (PC61; BioLegend), CD4 (GK
1.5; BioLegend), CD45 (30-F11; BioLegend), CD62L (Mel-14; BioLegend),
CD8 α (53-6.7; BioLegend), TCR Vβ TCRKIT (Becton Dickinson, Pharmin-
gen), Ulex Europaeus Agglutinin (Vector Laboratories), CD40 (HM40-3;
ebioscience), β-catenin (Becton Dickinson, Pharmingen)
PE: CD24 (M1/69; ebioscience), CD4 (GK 1.5; BioLegend), TCR α/β(H57-
597; BioLegend), Ly51 (6C3; BioLegend), CD45 5.1 (A20; BioLegend),
CD44 (IM7; BioLegend), FoxP3 (FJK-16s; ebioscience)
PECy7: CD62L (Mel-114; BioLegend), CD69 (H1.2F3; BioLegend), Nk1.1
(PK136 ; BioLegend), EpCAM (G8.8; BioLegend)
Cy5: UEA1 (Lectin; selfmade by K. Hafen), AIRE (5H11; selfmade by K.
Hafen)
APC: CD117 (c-kit) (2B8; BioLegend), CD103 (2E7; BioLegend)
Alexa647: EpCAM (G8.8; BioLegend), CD3 (KT3; selfmade by K. Hafen)
APCCy7: CD4 (W3/25 ;BioLegend), I-A/I-E (M5/114.1; BD Biosciences)
Alexa700: CD8 α (53-6.7; BioLegend), CD45 (30-F11; BioLegend)
Biotin: CD3 (KT3; selfmade by K. Hafen), CD4 (GK 1.5; selfmade by
K. Hafen), CD8α (53-6.7; BioLegend), CD11b (M1/70; BioLegend), CD11c
(N418; BioLegend), B220 (Ra3-6B2; BioLegend), CD19 (ID3; selfmade by
K. Hafen), CD45 (M1/9.3.4.HL2; selfmade by K. Hafen), EpCAM (G8.8;
selfmade by K. Hafen), TCR gamma/delta; (GL3; ebioscience), F4/80 (BM4;
BioLegend)
Strepavidin: APCCy7 (BioLegend), PerCPCy5.5 (BioLegend), PE-Texas
Red (Molecular Probes), PECy7 (BioLegend)
PerCPcy5.5: CD25 (PC61; BioLegend), CD45 (A20; BioLegend)
PE-Texas Red: CD19 (6D5; Molecular Probes)
Unlabelled: Rat monoclonal α-mouse EDG (S1P1) IgG, Rabbit polyclonal
α-human Raptor IgG A300-506 A (Bethyl Laboratories, Inc), Rabbit poly-
clonal α-human Raptor IgG A300-553 A (Bethyl Laboratories, Inc), Rabbit
polyclonal α-mouse Raptor IgG (Abcam plc), Mouse monoclonal α-mouse
Raptor IgG (Merck Millipore), Rabbit monoclonal α-human Raptor IgG
(OriGene)
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2.3 Cell isolation and flow cytometry
Characterization of cells by flow cytometry required the application of dif-
ferent isolation procedures, depending on the cellular size and the intended
staining.
2.3.1 Isolation of thymocytes
To obtain thymocytes, thymi were roughly cleaned from adherent fat and
connective tissue and placed between a folded piece of 40 µm gauze mesh.
The fully covered thymus was subsequently gently squeezed between both
mesh layers with the help of bent forceps until all thymocytes were released.
Residues of cells were cleaned from the meshes through several rinsing steps
using PBS 2% FCS.
2.3.2 Isolation of lymphocytes and splenocytes
Lymphocytes and splenocytes were isolated similarly as described in section
2.3.1. Unless otherwise stated, the following lymphnodes were used: axillary,
brachial, inguinal, mesenteric, para-aortic, iliacal.
2.3.3 Isolation of thymic stromal cells
Due to their cell size a different technique for the isolation of TEC was
performed. After removing the thymus from the thorax and cleaning of
the residues of fat and connective tissue, thymi were incubated 3 times for
15 min at 37◦C in HBSS containing 2% (w/v) FCS (Perbio), 100 mg/ml
Collagenase/Dispase (Roche Diagnostics), and 40 ng/ml DNase I (Roche)
for sequential digestion. The thymi were gently resuspended through a 1ml
pipette tip after each step of incubation and allowed to settle before col-
lecting the supernatant. For the last digestion step, the remaining thymic
organoids were resuspended through a double pipette tip, built up of a 1ml
and a 10 µl pipette tip until a homogenous cell suspension was achieved.
Cells were counted with a Z1 Coulter particle counter from Beckman Coul-
ter. Therefore three drops of zap-oglobin II lytic reagent from Beckman
Coulter and 20 µl of cell suspension (Beckman Coulter, Inc., Fullerton, CA,
USA) were added into 10 ml Isoton II.
2.3.4 Intracellular Staining
For intracellular staining, TEC were marked for cell-surface molecules, fixed,
permeabilized (Cytofix/Cytoperm; BD Biosciences according to the manu-
facture’s recommendation or in case of FoxP3 with fixatives and permeabi-
lization buffer from ebioscience), and stained with BrdU, β-catenin, Foxp3
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or Aire-specific antibodies. Unspecific staining was blocked using normal
mouse serum and 2.4G.2 supernatant, prepared in our laboratory.
2.3.5 Immunomagnetic Separation techniques
TEC were enriched using automated cell separation (AutoMACS; Miltenyi
Biotec). Depending on the individual experiment, TEC were either enriched
through positive selection of TEC or depletion of CD45 expressing cells. To
positively select TEC, cell concentration was adjusted to 100 x 106cells/ml
and incubated with biotinylated α-EpCAM antibodies for 15 min on ice.
After washing, cells were incubated with α-Biotin beads (10 x 106 µl/ 10 x
106 cells) for 15 min at 4◦. Subsequently, the cells were washed and filtered
twice (through a 70 µm and 40 µm). Before running “possel”, Dnase I
(Roche) was added (100 µg/ml). Alternatively, to deplete CD45 expressing
cells, cell concentration was adjusted to 100 x 106cells/ml and incubated
with α- CD45 beads (5 x 106 µl/ 10 x 106 cells) for 15 min at 4◦C. Cells
were subsequently washed and filtered twice (through a 70 µm and 40 µm).
Before running “deplete”, Dnase I (Roche) was added (100 µg/ml).
2.3.6 Flow Cytometry
Measurement of autophagy
To measure of autophagy the Cyto-ID Autophagy Detection Kit (Roche)
was used. To prepare CytoID Green detection solution, 1 µl of CytoID
Green was added reagent to 4 ml FACS buffer. A maximum of 1 x 106
pre-enriched thymic cells/ml were resuspended in 0.5ml of freshly diluted
Cyto ID detection reagent and incubated for 30 min at 37◦ in the dark.
After incubation, cells were filtered through a 40 µm mesh and and directly
analysed on FACS-Aria II without prior washing.
Measurement of cleaved caspases
To measure apoptosis, the the CaspACETM FITC-VAD-FMK In Situ Mar-
ker (Promega) was used. The CaspACETM FITC-VAD-FMK In Situ Marker
is a labeled derivative of the cell-permeable irreversible pan-caspase in-
hibitor, Z-VAD-FMK, which binds to cleaved caspases and label them fluo-
rescently. For detection, the TEC-enriched and surface-stained thymic cell
suspension was adjusted to 0.6 x 106 cells/ml, pelleted and resuspended in
500 µl FACS buffer including CaspACETM FITC-VAD-FMK In Situ Marker
at a final concentration of 10 µM. Cells were subsequently incubated for 30
min at 37◦C protected from light. After washing, cells were filtered through
a 40 µm mesh and analysed on FACS-Aria II.
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Measurement TUNEL
Cell death was measured using the In Situ Cell Death Detection Kit, Fluo-
rescein (Roche).
To measure cell death, the positively selected TEC were surface-stained.
The cell concentration was adjusted to 2 × 107 cells/ml. Next, 100 µl cell
suspension was transferred into a V-bottomed 96-well microplate and mixed
with 100 µl/well of a freshly prepared fixation solution (final concentration
2% PFA). Cells were subsequently incubated for 60 min at 15-25◦C on a
shaker, protected from light. After washing the sample three times with
PBS, cells were resuspended in 100 µl permeabilisation solution and kept
for 2 min on ice. Cell were washed twice with PBS and resuspended in
50 µl TUNEL reaction mixture and incubated for 60 min at 37◦C in a
humidified atmosphere in the dark. After washing the samples twice with
PBS, cells were resuspended in FACS buffer, filtered through a 40 µm mesh
and analysed on FACS-Aria II.
BrdU labelling and detection
For cell cycle analysis, mice were injected with BrdU (BD Pharmingen) (1
mg/mouse i.p.) and analysed at the time points indicated. Detection of
cell-labeling was performed using the BrdU Flow Kit (BD Pharmingen),
according to the manufactor’s recommendations. For BrdU detection, TEC
were enriched using AutoMACS program: “possel”.
Cell sorting
The cells were sorted on a FACS Aria II (BD) into collection tubes, which
were pre-wetted and coated using FACS buffer. Sort purity was evaluated
for each sorted population, using between 200-1000 cells (depending on the
cell number sorted).
2.4 Imaging-techniques
2.4.1 Tissue embedding
Freshly isolated organs were cleaned from connective tissue and embedded
in OCT compound (Medite, Switzerland) in Tissue-Tek Cryomolds (Miles
Inc., Elkhart, USA). Tissues were frozen in methyl-butane cooled with dry
ice and then stored at -80◦C.
2.4.2 Sectioning and Fixation of Tissues
Sectioning of OCT embedded organs was performed at a cryostat Leica 3050
(Leica Biosystems). Tissue sections were recovered on microscope slides, pre
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cleaned/ready-to-use from Thermo Fisher Scientific Inc.
2.4.3 Preparation of cytospins
Cytospins were prepared from sorted TEC and respective control cells, using
a Cytospin device composed of Cytospin filter cards for cyto-centrifugation
(Thermo, 3424) and Cytospin microtubes 0.75 ml, with 0.5 mm bottom
hole (Thermo, 1153). The cells were resuspended in 150 µl PBS + 2%, and
transferred to the cytospin microtube positioned in the assembled cytospin
device. The device was placed in a centrifuge equipped with a swing out
rotor and spun at 100g for 1 min. Subsequently the cytospin device was
carefully disassembled. Depending on the respective staining slides were
processes as described in sections 2.4.4 and 2.4.5.
2.4.4 Hematoxylin and Eosin (HE) staining
OCT (Tissue-Tek, Sakura Finetec, Netherlands) embedded tissues were cut
at 8 µm thickness. Tissues were air dried over night at RT, then either frozen
at 80◦C or processed directly. Sections were fixed in Delaunay’s fixation
solution for 1 min, then rehydrated in a series of ethanol dilutions for 1 min
each: 100% ethanol, 96% ethanol, 70% ethanol, 50% ethanol and water.
Tissues were then stained with Meyer’s Ha¨malaun for 2 min. Afterwards
the slides were washed with luke warm water 3 times 1 min before staining
with 1% Erythrosin. After washing with water for 1 min, sections were
dehydrated in a series of ethanol solutions: 50% ethanol, 70% ethanol, 96%
ethanol for 1 min each, then ethanol 100% for 2 min. Slides were then air
dried before cover slips were mounted with Pertex (Histolab, Products AB).
Images were acquired using a Nikon Eclipse E600.
2.4.5 Immunohistochemistry
For immunohistochemistry tissue sections were prepared as described for the
HE staining. Sections were fixed in acetone at RT for 10 min and briefly air
dried. Samples were circled with a pap-pen (Sigma-Aldrich). Tissues were
then washed 3×5 min in PBS. Slides were then transferred to a wet chamber
and overlayed with 5% goat serum (Gibco) to cover each sample and left at
RT for 15 min – 30 min. After blocking, tissues were stained with primary
antibodies and incubated for a min of 1h in a wet chamber at RT. After
washing the slides 3× 5 min in PBS, secondary antibodies were applied and
incubated for 30 min in the dark at RT. Sections were then again washed
3×5 min in PBS and stained with DAPI for 2 min. After washing 1×5 min,
tissues were embedded in Hydromount (National Diagnostics). Primary and
secondary antibodies were prepared 5% goat serum (Gibco) diluted in PBS.
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2.4.6 Antibodies used for immunohistochemistry
Antibodies used for flow cytometry are listed in section 2.2.2.
CK5 (Covance), CK8 (Progen), MTS10 (a gift from R. Boyd, Melbourne,
Australia), ERTR7 (provided by W. van Ewijk, Utrecht, The Netherlands),
Aire (5H12; provided by S. Hamish, Adelaide, Australia), Ng2 ( Abcam plc),
CD31-FITC (390; ebiosciene), Rat monoclonal α-mouse EDG (S1P1) IgG,
Rabbit polyclonal α-human Raptor IgG A300-506 A (Bethyl Laboratories,
Inc), Rabbit polyclonal α-human Raptor IgG A300-553 A (Bethyl Labora-
tories, Inc), Rabbit polyclonal α-mouse Raptor IgG (Abcam plc), Mouse
monoclonal α-mouse Raptor IgG (Merck Millipore), Rabbit monoclonal α-
human Raptor IgG (OriGene), and reactivity to lectin UEA-1 (Reactolab).
Alexa Fluor-conjugated anti-IgG antibodies (Invitrogen) were used as
secondary reagents. Images were acquired using a Zeiss LSM510 (Carl Zeiss).
2.5 Molecular biology
2.5.1 PCR
Primer pairs and PCR conditions are described in the section 2.1.3.
RNA isolation from cells
Total RNA was isolated from sorted TEC (or control populations) using the
RNeasy micro Kit (Quiagen GmbH) according to the manufacturers recom-
mendations. The isolated RNA was stored at -80◦C until further processing.
The quality and quantity of the isolated RNA was measured on a NanoDrop
1000 (Thermo Fisher Scientific).
cDNA synthesis
cDNA was synthesized by reverse transcription using Superscript III RT
(Invitrogen). Reaction mix 1 contained:
10 µl total RNA
1 µl dNTP(10 µM)
1 µl dT20 (1 µM, Microsynt)
1 µl Random Hexamer (500 ng/µl Sigma)
Mix 1 was denatured for 5 min at 65◦C in a Mastercycler gradient (Ep-
pendorf) and kept for 1 min on ice before adding:
4.5 µl 5x first strand buffer
1 µl DTT (0.1 M, Invitrogen)
1 µl RNaseOUT (40 U/µl, Invitrogen; added in case of low material)
1 µl Superscript III RT (200 U/µl, Invitrogen)
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cDNA synthesis was performed on Mastercycler gradient (Eppendorf)
using the following conditions:
Incubation: 25◦C 5 min
Incubation: 50◦C 60 min
Activation of the reaction: 70◦C 15 min
Inactivation of the reaction: 16◦C 5 min HOLD
The samples were either directly used or stored at -20◦C.
2.5.2 qPCR
qPCR was performed using SensiMix dT Kit (Quantace Ltd). The reaction
mix was prepared in 0.1 ml strip tubes from Corbett Research (Corbett
Research). The reaction was performed on Rotor-Gene 3000A (Corbett Re-
search).
6.25 µl Sensimix 2x (Quantace)
0.375 µl forward primer (10 µM)
0.375 µl reverse primer (10 µm)
0.25 µl 50x SYBR Green I solution (Quantace)
4.25 µl distilled water
2.75 µl cDNA (20 ng/µl)
The cycle threshold (CT) was set at 0.1. CT values were used for the
calculation of the relative expression difference between control and target
samples assuming an amplification efficiency of 100%. Calculation was based
on the comparative CT Method, known as the 2(∆∆CT ) method, whereby the
CT values of both the calibrator and the samples of interest were normalized
to GAPDH.
Primer
The following primer pairs were used on cDNA:
Raptor deletion on cDNA:
(fw) CTTCAACAAGAACTACACTCAG;
(rv) TGGATGGTTTGGGTTAATCG
Rictor deletion:
(fw) TTATTAACTGTGTGTGGGTTG;
(rv) CAGATTCAAGCATGTCCTAAGC
Ccl19:
(fw) CCTGGGTGGATCGCATCATCCG;
(rv) AGAGCATCAGGAGGCCTGGTCCT
Ccl21:
(fw) TTATTAACTGTGTGTGGGTTG;
(rv) TTCCAGACTTAGAGGTTCCCCG
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Ccl25:
(fw) GTTACCAGCACAGGATCAAAT;
(rv) GGAAGTAGAATCTCACAGCA
Cxcl12:
(fw) AAATCCTCAACACTCCAAAC;
(rv) GCTTTCTCCAGGTACTCTTG
IL-7:
(fw) ATTATGGGTGGTGAGAGCCG;
(rv) GTTCATTATTCGGGCAATTACTATCA
GADPH:
(fw)GGTGAAGGTCGGTGTGAACG;
(rv) ACCATGTAGTTGAGGTCAATGAAGG
Primer pairs used for genotyping are listed in section 2.1.3.
2.5.3 GeneChip Array
TEC were sorted in biological triplicates from three wild type and three
mutant mice at E16 and at 2 weeks. TEC of 2 week old mice were further
separated into cTEC and mTEC. Sorted cells constituted only DAPIneg
TEC. Sort purity was greater than 95%. Total mRNA was isolated from
sorted cells using the RNeasy micro Kit (Quiagen GmbH) according to the
manufacturer’s recommendations. The Ambion WT Expression kit was used
for target preparation on GeneChip 1.0 ST Array System (Affymetrix).
2.6 In vitro experiments
2.6.1 T-cell activation assay
In vitro competence of T-cells was assessed with (1 x 105) sorted Tna¨ıve
CD4posCD25negCD44neg or CD8posCD44neg T-cells from Raptorlox/lox and
Raptorlox/lox;Foxn1Cre mice. If possible, cells were plated in triplicates of
one individual mouse. To assess cell proliferation, the sorted na¨ıve T-cells
were resuspended in PBS and labelled with carboxyfluorescein diacetate
succinimidyl ester (CFSE; Molecular Probes). Cells were cultured in 96-
well plates in IMDM culture medium in the presence of the indicated α-
CD3 mAB concentrations and lethally irradiated splenocytes (1 x 105) from
RAG 2 deficient mice. Plates were covered with foil to avoid evaporation and
kept at 37◦C. After three days, the cells were carefully harvested, stained,
filtered and analysed on FACS ARIA II. Proliferation was measured using
the “Expansion Index” calculated by FlowJo Software (TriStar).
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2.6.2 Treg-suppression assay
The potency Treg was assessed in an Treg-suppression assay. CD4
posCD25neg
CD44neg T-cells (“responder”-cells) of C57BL/6 5.1 mice were isolated from
lymphnodes, sorted and labelled with CFSE. Additionally, CD4posCD25pos
from Raptorlox/lox and Raptorlox/lox;Foxn1Cre mice were isolated from lym-
phnodes and sorted. 2 - 5 x 104 responder cells were transferred into a
96-well plate and cultured together with regulatory T-cells in different dilu-
tions in IMDM culture medium in the presence of α-CD3 (1µg/ml). Plates
were covered with foil to avoid evaporation and kept at 37◦C. After three
days, the cells were carefully harvested, stained, filtered and analysed on
FACS ARIA II. Proliferation was measured using the “Expansion Index”
calculated by FlowJo Software (TriStar).
2.7 In vivo experiments
2.7.1 Colitis induction by adoptive transfer of naive CD4pos
T-cells
In vivo competence of T-cells was assessed by adoptive transfer of sorted
na¨ıve T-cells (CD4pos CD25neg CD44neg) from wild type and mutant mice
to RAG 2 -/- mice. The sorted cells were resuspended in Hank’s Buffered
Salt Solution (HBSS) and injected intravenously into the tail of Rag 2 defi-
cient mice (250µl/mouse). Mice were monitored for clinical signs of disease
(diarrhea, fur, hunched back) and weight every other day. Endpoint of the
experiment was determined as 20% weight loss of the maximum weight of
each individual mouse.
2.8 Statistics
The statistical calculations were carried out using Graphpad Prism6 and
Numbers 09. The probability values were calculated with student’s t-test
(unpaired, two-tailed). p > .05 were considered as non-significant, *p < .05;
**p < .01; ***p < .005).
40
Chapter 3
Results
3.1 Mouse models of TEC-targeted loss of mTOR
function
Three different mouse models have been established to investigate sepa-
rately the role of either signalling pathway on mouse thymic epithelium,
and to evaluate their respective contribution to the overall block of mTOR
signalling. The comparison of the different mouse models also allowed us to
interrogate whether the combined loss of mTORC1 and mTORC2 function
could result in a phenotype that would be the sum of each of the defects
of a singular loss of signalling engaging these complexes. Alternatively, the
double mutant may reveal that concomitant loss of mTORC1 and mTORC2
results in a much stronger phenotype compared to their individual deletion.
3.1.1 mTORC1 inhibition in Raptorlox/lox;Foxn1Cre mice
Raptorlox/lox; Foxn1Cre
Foxn1Cre
TEC-specific > 
 E 11.5
   
X
Foxn1 Cre
Raptorlox/lox  
Foxn1 Cre
Lo
xP5 7
5
Lo
xP
Lo
xPExon 7ExonExon 6
Exon Exon
Mittwoch, 18. September 2013
Figure 3.1: Conditional deletion
of raptor in Raptorlox/lox;Foxn1Cre
mice; To obtain a TEC-targeted dele-
tion of raptor, mice homozygous for exon
6 flanked by loxP sequences were crossed
to Foxn1 Cre mice. Cre-mediated recom-
bination deletes exon 6 and leads to a
frameshift-induced translational stop.
To study the consequences of mTORC1 inhibition in TEC, conditional
knockout mice were generated that lack the expression of the mTORC1-
specific component Raptor in these cells. For this purpose, we crossed
mice homozygous for LoxP flanked raptor exon 6 (Cybulski et al., 2009)
to Foxn1Cre mice, i.e. animals that express the recombinase in all thymic
epithelia (Fig. 3.1). As LoxP sites function as target sites for the Cre re-
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combinase, the gene(s) flanked by the LoxP sites are deleted in each cell
expressing Cre. In Raptorlox/lox;Foxn1Cre mice, Cre-mediated recombination
deletes exon 6 of the raptor gene, leading to a frameshift induced stop of
translation and therefore to a lack of Raptor protein in Foxn1 expressing
cells. Cre-specific recombination in Foxn1 Cre mice can be detected as early
as E11.5 (Zuklys et al., 2009).
To characterize the mouse model, DNA and RNA were isolated from
sorted embryonic TEC (E14) and analysed for the presence of the recom-
bined locus as well as for raptor specific transcripts (Fig. 3.2). Detection of
raptor protein was assessed by FACS, immunohistochemistry and cytochem-
istry. Five different commercially available antibodies designed for the de-
tection of either murine and/or human Raptor protein were tested on thymic
tissue sections and/or isolated cells (cytospins). As Raptor is ubiquitously
expressed in the cytoplasm of all cells (Sancak et al., 2008), including thymo-
cytes and non-TEC stromal cells, antibodies directed against epithelial ker-
atins were added to the staining to identify the cell type that has lost its Rap-
tor expression in the thymus. Stainings of tissue sections of 1w old thymi,
revealed areas, where the signal for both, Raptor protein and epithelial-
specific keratin overlapped in control Raptorlox/lox mice. In contrast, such
overlap of staining signals were not observed in Raptorlox/lox;Foxn1Cre mice.
(Fig. 3.3).
The vicinity to developing thymocytes and non-epithelial stromal cells
complicated a clear allocation of the cellular source of Raptor, therefore we
also tested all antibodies for their potential to detect Raptor protein using
FACS. Unfortunately, none of the five antibodies tested revealed a believable
(i.e sharp) signal in wild type TEC, precluding the detection of raptor by
flow cytometry (data not shown).
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Figure 3.2: Confirmation of raptor deletion; (A) Extract of the raptor gene on genomic
DNA and cDNA depicted for Raptorlox/lox mice (upper panel) and Raptorlox/lox;Foxn1Cre mice
(lower panel). Labelled arrows are representative for the different primers that were used for raptor
detection. (B) Primer pairs and sequences. (C) Genomic deletion of exon 6 was verified on sorted
non-TEC (CD45neg EpCAMneg) and TEC (CD45neg EpCAMpos) stromal cells from E14 thymic
tissue. Rectangles on FACS plots are displaying sorting gates for both cell populations. Deletion
was confirmed by genomic PCR using primer pair 1 and 2. The recombined locus provides an
amplification product of 204bp, while its wild type counterpart generates a product of 869bp size.
(D) Absence of raptor transcript was confirmed by rtPCR of sorted TEC of embyros at day 14
and 16.5 using primers 3 and 4. As primer 4 was designed to recognize a sequence from exon 6, a
product will not be generated once successful deletion of exon 6 has occurred. Expression levels
for Raptor mRNA were normalized to GAPDH mRNA levels in the same sample and are shown
as fold increase relative to wild type TEC.
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Figure 3.3: Raptor protein detection; Thymic tissue sections (8 µm) of gestational day
17.5 ( (A/B) and (1w) (C/D) old Raptorlox/lox control mice (left) and Raptorlox/lox;Foxn1Cre
mice (right) were stained for Cytokeratin (K)-8 (green), K5 (blue) and raptor (red). Filled white
rectangles indicate colocalization of raptor protein in medullary (K5 positive) TEC; empty white
rectangles highlight raptor-detection in cortical (K8 positive) TEC. Figures have been taken at
60x magnification.
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3.1.2 mTORC2 inhibition in Rictorlox/lox;Foxn1Cre mice
To investigate the role of mTORC2 signalling for TEC biology, conditional
knockout mice were generated lacking the expression of Rictor in these cells
(Fig. 3.4). Similar to the generation of Raptorlox/lox;Foxn1Cre mice, the
Cre/LoxP system was used to generate the tissue-conditional deletion. Mice
harboring rictor gene-targeted alleles with LoxP sites flanking exon 4 and 5
have been crossed to transgenic mice expressing Cre recombinase under the
control of the Foxn1 promotor. The resultant mice are designated in this
thesis as Rictorlox/lox;Foxn1Cre mice.
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Figure 3.4: Conditional deletion of
rictor in Rictorlox/lox;Foxn1Cre mice;
Mice homozygous for LoxP flanked exons 4
and 5 were crossed to Foxn1 Cre mice. Fol-
lowing Cre mediated recombination exons
4 and 5 of the rictor gene are deleted lead-
ing subsequently to a frameshift-induced
stop of translation.
3.1.3 Block of mTOR in Raptorlox/loxRictorlox/lox;Foxn1Cre mice
Combining the two already existing mouse models with a selective block-
ade of either mTORC1 or mTORC2 signalling in the thymic epithelium, a
third conditional knockout mouse — the Raptorlox/loxRictorlox/lox;Foxn1Cre
mouse (Fig. 3.5) — was created. Again, transcription of Cre was targeted
to TEC using the Foxn1 locus to drive the recombinase. LoxP-mediated
recombination of the targeted Raptor and Rictor loci results in a complete
loss of mTOR signalling within TEC. The resultant mice are designated
Raptorlox/loxRictorlox/lox;Foxn1Cre mice.
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Mittwoch, 18. September 2013
Figure 3.5: Conditional deletion of
raptor and rictor in Raptorlox/lox
Rictorlox/lox;Foxn1Cremice; TEC-
restricted Rictor-Raptor double knock-
outs were generated by crossing mice
individually homozygous for LoxP flanked
raptor exon 6 or rictor exons 4 and
5, respectively. This cross resulted in
mice homozygous for Rictor and Raptor
knock-in alleles. Further breeding with
transgenic mice expressing the Cre
recombinase under the control of Foxn1
regulatory elements, resulted in the
deletion of Raptor and Rictor protein in
TEC.
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3.2 Comparative analysis of mice with a loss of
mTOR function in TEC
The generation of three different mouse lines with either a single conditional
loss of mTORC1 or mTORC2 function via the deletion of raptor and rictor,
respectively, or a combined loss of these regulatory components of the mTOR
pathway allowed a comparison of the deficiencies.
Analysis of thymi from newborn mice, bearing a deficiency for either
Rictor, Raptor or both proteins showed, that both the single absence of
Rictor and the combined absence of Rictor and Raptor in TEC results in
a significant reduction of thymic size already in neonatal thymi (14.6 ×
106 ± 2.7 × 106 in wild type mice vs. 5.9 × 106 ± 1.9 × 106 (***p < .005)
in Rictorlox/lox;Foxn1Cre mice and 1.6 × 106 ± 0.5 × 106 (***p < .005) in
Rictorlox/loxRaptorlox/lox;Foxn1Cremice) (Fig. 3.6 A, B). The selective dele-
tion of Raptor, however, did not result in significant changes in total thymic
cellularity when compared to thymi of age-matched wild type littermates
(12.4× 106 ± 0.5× 106 in Raptorlox/lox;Foxn1Cre mice).
Further analysis of thymi from 2 week old wild type and mutant mice
revealed, however, the importance of both single mTOR complexes for the
thymic epithelia. In comparison to their age-matched wild type littermates,
each conditional knockout mouse displayed a significant albeit different de-
crease in total thymic cellularity. TEC-restricted Rictor-deletion showed on
inspection the least, total blockade of mTOR signalling the most impact on
organ size (Fig. 3.7 A). These changes were mirrored by quantification of
total thymic cellularity (Fig. 3.7 C). Thymi from Rictorlox/lox;Foxn1Cre mice
had only half of the total cellularity observed in wild type mice, whereas
Raptorlox/lox;Foxn1Cre mice displayed a reduction of 65% when compared to
wild type mice. The most pronounced impact on total thymic cellularity
was observed in mice without any mTOR signalling in their TEC. Instead
of 328× 106± 17× 106 total thymic cells, the double mutant mice had only
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Figure 3.6: Inhibition of mTORC2 and mTOR signalling in TEC impaires normal
neonatal thymic development; (A i-iv) Representative photographs from neonatal thymi of
different selective conditional knockout mice and their respective wild type littermates; (A i) from
wild type mice ; (A ii) from Rictorlox/lox;Foxn1Cre mice (A iii) from Raptorlox/lox;Foxn1Cremice
and (A iv) from Rictorlox/loxRaptorlox/lox;Foxn1Cremice. (B) Absolute numbers of total thymic
cells after flow cytometric analysis of thymi. Values represent the mean plus SD. Per experiment
a minimum of 3 mice were used. p values were determined by Student’s t test with *p < .05; **p
< .01; ***p < .005)
46
BC
Wild type
Rictorlox/lox; Foxn1Cre
Rictorlox/lox Raptorlox/lox;Foxn1Cre
Raptorlox/lox; Foxn1Cre
0.1 0.1
6.1
92.4
13.2
84.4
20.2
75.5
0.7
93.3
2.4
Fr
eq
ue
nc
y (
%
)o
f T
EC
s
0
20
40
60
80
100
cTEC
To
ta
l C
ell
ula
rit
y (
10
4 )
0
5
10
15
20
25
mTEC
***
**
***
**
**
***
To
ta
l C
ell
ula
rit
y (
10
4 )
0
1
2
3
4
5
cTEC
Fr
eq
ue
nc
y (
%
)o
f T
EC
s
0
20
40
60
80
100
mTEC
*
*
***
0.00
0.05
0.10
0.15
0.6
0.8
1.0
TECF
re
qu
en
cy
 (%
) i
n 
th
ym
us
0
5
10
15
20
25
TECT
ot
al 
Ce
llu
lar
ity
 (1
04
)
***
**
***
***
EpCAM
UEA1
CD
45
Ly
51
Wild type Rictorlox/lox; Foxn1Cre Raptorlox/lox; Foxn1Cre Rictor
lox/lox 
Raptorlox/lox;Foxn1Cre
A
gated on 
all cells
gated on 
TECs
0.09
1 2
3mm
0.5mm
1
10
100
1000
Thymus
***
**
***
To
ta
l C
ell
ula
rit
y (
10
6 )
98.9
67.3
32.4
FSC
M
HC
II
gated on 
TECs
63.4
28.3
3mm3mm
3
1.24
98.8
67.6
32.4
Figure 3.7: Inhibition of mTOR signalling in TEC leads to thymic hypopla-
sia and a loss of mTEC; (A1-3) Representative photographs from 2 week old thymi
of different selective conditional knockout mice and their respective wild type littermates;
(A1) Rictorlox/lox mice (left); Rictorlox/lox;Foxn1Cre mice (right) (A2) Raptorlox/lox
mice (left); Raptorlox/lox;Foxn1Cre mice (right) (A3) Rictorlox/loxRaptorlox/loxmice (left);
Rictorlox/loxRaptorlox/lox;Foxn1Cremice (right). Boxed area is shown in higher magnification
to point out cysts (arrows) present in Rictorlox/loxRaptorlox/lox;Foxn1Cremice.(B) Flow cyto-
metric analysis of TEC from the indicated mouse lines. TEC were defined as CD45neg EpCAMpos
cells (gates in upper panels). To further subdivide TEC into cTEC and mTEC, cells have been
stained for UAE1 reactivity and Ly51 expression (middle panels). Gates are highlighting cTEC
(Ly51pos and UEA1neg) and mTEC (Ly51neg and UEA1pos). MHCII expression has been used
to distinguish MHCIIlow TEC and MHCIIhigh TEC (lower panels). The relative frequency of
the distinct subpopulations is provided as a percentage. (C) Absolute numbers of total thymic
cells, TEC as well as TEC subpopulations (upper line) of thymi from 2 week old wild type mice
as indicated. Relative numbers of TEC per thymus and proportion of cTEC and mTEC among
TEC are shown at the lower line. Values represent the mean plus SD. (The number of mice
analysed per experiment is n = 10 for Rictorlox/loxmice; n = 8 for Raptorlox/loxmice and n = 6
for Rictorlox/loxRaptorlox/loxmice; p values were determined by Student’s t test with *p < .05;
**p < .01; ***p < .005)
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1.7 × 106 ± 0.7 × 106 total cells per thymus. In addition, large cysts were
present in thymi of Raptorlox/loxRictorlox/lox;Foxn1Cre mice (Fig. 3.7 A3) but
not in the other mutant mice. FACS analysis of mutant and wild type thymi
revealed also distinct consequences of partial or general inhibition of mTOR
signalling for the cellular composition of the thymus. Although the relative
frequency of TEC within the thymus of single knockouts was not signifi-
cantly changed, Raptorlox/loxRictorlox/lox;Foxn1Cre mice displayed a 7-fold
higher TEC to thymocyte ratio in comparison to wild type mice (Fig. 3.7
C). All three mouse models showed progressive changes in the representation
of specific TEC subsets when analysing the TEC compartment in further
detail (Fig. 3.7 B). Thymi deficient for Rictor protein expression in TEC
showed a mild but significant reduction in the frequency of medullary TEC
(e.i. UEA1pos, Ly51neg) (90.3% ± 1.7% in wild type vs. 85.1% ± 1.7% in
Rictorlox/lox;Foxn1Cre mice; (***p < .005)). The frequency of mTEC was
more profoundly reduced in Raptorlox/lox;Foxn1Cre mice (95.4% ± 0.7% in
wild type vs. 69.7% ± 6.8% in Raptorlox/lox;Foxn1Cre mice; (***p < .005)).
In sharp contrast, in Rictorlox/loxRaptorlox/lox;Foxn1Cre mice only a marginal
population of 3.7% ± 1.7% of all TEC were mTEC. In absolute numbers,
the reduction of both total thymic cellularity and mTEC frequency resulted
in a decrease in total mTEC. Changes in mTOR signalling did not affect the
absolute numbers of cTEC, though it affected their relative frequency due to
the overall decrease in thymic cellularity. Remarkably, partial or total inhi-
bition of mTOR did not lead to any significant quantitative changes within
the cTEC compartment, even though total thymus cellularity was partic-
ularly reduced in Raptorlox/loxRictorlox/lox;Foxn1Cre mice. Comparison of
MHCII expression on TEC isolated from mutant mice revealed a normal
MHC phenotype for the Raptor- and Rictor-deficient cells. However, a total
block in mTOR signalling resulted in a complete loss of the MHCIIhigh TEC
population (Fig. 3.7 B). This finding suggests that mTOR mediated signals
are essential for MHCIIhigh cell surface expression.
To evaluate whether the observed changes in TEC number and quality
had functional consequences in particular for thymopoiesis, T-cell develop-
ment was next analysed by flow cytometry (Fig. 3.8 B). Thymi from the
three different mouse lines, and wild type littermates at 2 weeks of age were
investigated for the frequency of specific thymocyte subpopulations within
the TCR α/β lineage. Similar to the differential impact on thymic size
and TEC quality, the deletion of single mTOR signalling components had a
differential impact on intrathymic T-cell maturation. In mice deficient for
Rictor expression in TEC, the frequencies of DN, DP and SP thymocytes
were almost unperturbed, except for a minor reduction in the frequency of
SP CD8pos T-cells (1.1% ± 0.2% in wild type vs. 0.7% ± 0.1%; (*p <
.05) in Rictor-deficient mice). Lack of Raptor led to a slight but significant
change in the relative amount of DP (82% ± 1.6% in wild type vs. 87%
± 1.6%; (*p < .05) in Raptor-deficient mice) and CD4pos T-cells (10.2% ±
48
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Figure 3.8: Inhibition of mTOR signalling in TEC impaires normal thymocyte devel-
opment; Thymic cell suspensions of two week old mice lacking expression of either rictor, raptor
or both proteins in TEC were stained for CD4 and CD8 cell surface expression and analysed by
flow cytometry. Cell suspension of wild type littermates served as controls. (A) Representative
FACS plots of total thymocytes. DAPIpos cells and doublets have been excluded prior to analy-
sis. Frequencies of the respective thymocyte subpopulation are indicated next to each gate. (B)
Frequencies of DN, DP, as well as CD4 and CD8 single positive thymocytes are calculated and
compared to values of age-matched wild type littermates. Values represent the mean plus SD. (C)
Flow cytometric profile of CD3 surface expression on thymocytes; the gate indicates the percent-
age of cells expressing high CD3 concentrations. (D) Statistical analysis of CD3high frequencies
in thymi of the mice indicated. Values represent mean frequencies plus SD. (The number of mice
analysed per experiment is n = 10 for Rictorlox/loxmice; n = 8 for Raptorlox/loxmice and n = 6
for Rictorlox/loxRaptorlox/loxmice; p values were determined by Student’s t test with *p < .05;
**p < .01; ***p < .005)
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Figure 3.9: Selective mTOR inhibition impaires thymocyte maturation; (A) Repre-
sentative FACS plot of thymocytes stained for surface expression of CD69 and CD3. Gates R1-R3
drawn in the plot are defining distinct thymocyte subpopulations that have undergone positive
selection. Mean frequencies of thymocytes within gate R1-R3 have been normalized to mean wild
type frequencies and are depicted as colored triangles (light grey for Rictorlox/lox;Foxn1Cre mice;
grey for Raptorlox/lox;Foxn1Cre mice and black for Rictorlox/loxRaptorlox/lox;Foxn1Cremice.)
(B) Gating scheme illustrates characterization of immature and mature CD4 and CD8 T-cells
for comparative analysis of their relative amount in the thymus. Immature CD4 thymocytes are
characterized by high expression of CD24 and CD69, whereas mature CD4 positive cells express
lower amounts of CD69 and are negative for CD24. In order to restrict the analysis to post-
selection thymocytes, CD8 positive cells that do not express CD3 on their surface were excluded
from further analysis in a first step. The remaining CD8 SP cells were subsequently further
subdivided into immature and mature cells, according to their surface expression of CD69 and
CD24 similarly to CD4 T-cells. Values are indicated as means plus SD. (The number of mice
analysed per experiment is n = 10 for Rictorlox/loxmice, n = 8 for Raptorlox/loxmice and n = 6
for Rictorlox/loxRaptorlox/loxmice; p values were determined by Student’s t test with *p < .05;
**p < .01; ***p < .005)
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1.2% in wild type vs. 7.3% ± 0.8% in raptor-deficient mice). In contrast,
Raptorlox/loxRictorlox/lox;Foxn1Cre mice demonstrated large changes in the
frequency of DP and SP thymocytes. The frequency of DP cells was in-
creased from 79.3% ± 3.2% in wild type to 93.5% ± 0.1% (***p < .005) in
the mTOR double mutant mouse. In parallel, the relative frequency of CD4
and CD8 SP thymocytes was strongly decreased in comparison to controls;
instead of the observed frequencies of 11.9% ± 2.1% CD4pos cells and 2.5%
± 0.4% CD8pos cells in wild type, thymi of mTOR double mutant mice con-
tained only 2.3% ± 0.1% CD4pos cells (**p < .01) and 0.4% ± 0.1% CD8pos
cells (***p < .005). These results suggested changes in positive thymocyte
selection; a contention further underscored by a significantly lower relative
frequency of CD3high cells (Fig. 3.8 C and D) in the mTOR double mutant
mice (3.7% ± 0.9%) in comparison to wild type mice (12% ± 2.5%; **p <
.01).
The observed reductions in the frequencies of mature thymocytes were
suggestive of an impaired potential of the genetically modified TEC to sup-
port positive selection. It was therefore of interest to investigate differences
in thymocyte maturation between the three mouse models using phenotyp-
ing and quantification by FACS analyses (Fig. 3.9 A). Thymocytes follow
well-defined changes in CD69 and CD3 expression during their development
from DN to SPs. Early immature thymocytes are CD3low and do not yet un-
dergo positive selection. Concurrent with an upregulation on the cell surface
of the TCR/CD3 complex, positive selection of DP thymocytes is enabled.
Successful positive selection results in the up-regulation of CD69. This se-
quence of phenotypic changes allows a close monitoring of the efficiency of
thymocyte positive selection without the need to define the specificity of
the TCRs engaged. In Fig. 3.9 A, thymocytes with an early positive se-
lection phenotype, (i.e. CD69pos CD3int) are defined in gate “R1”. Next,
thymocytes upregulate concomittantly the expression of CD3 and CD69,
resulting in a thymocyte population that is CD69pos and CD3high (“R2” in
Fig. 3.9 A). Finally, mature thymocytes tune down CD69 expression while
maintaining a high cell surface density of the CD3/TCR complex (“R3” in
Fig. 3.9 A). The mean frequencies of thymocytes within the gates “R1”,
“R2”, and “R3” were then compared for the three strains of mice to assess
the severity of changes in positive thymocyte selection. All knockout values
were normalized to those obtained in wild-type animals (Fig. 3.9 A). Ex-
cept for early postselection-thymocytes in gate “R1” and “R2” derived from
Rictor-deficient thymi, thymocytes of each genetically modified mouse were
less frequent in each of the defined gates (“R1–R3”) than in wild type. The
extent of the impairment correlated with the other changes observed and was
again most prominent in mice with a complete lack of mTOR signalling.
An additional approach to measure post-selectional maturation focuses
more on the maturational state of CD4 and CD8 SP thymocytes and quan-
tifies CD24 and CD69 surface-expression of SP (Fig. 3.9 B). CD4pos and
51
CD8pos thymocytes can be classified as “immature” and “mature” depend-
ing on the pattern of CD69 and CD24 expression. Immature SP thymocytes
are positive for both markers, whereas mature cells lose CD24 expression.
Due to asymmetric up-regulation of CD4 and CD8 during the transition
from DN to DP thymocytes, the population of CD8pos cells consists of two
distinct subpopulations. The so-called immature single positive (ISP) cells
have not yet undergone positive selection and were therefore excluded from
the analysis on the basis of their low CD3 expression (Fig. 3.9 B gating
scheme). Two thirds of CD4 and one third of CD8 SP thymocytes in wild
type mice are immature according to the phenotypic staging. These propor-
tions were significantly altered in mutant mice. 70% ±2.3% of all CD4pos
cells in Rictorlox/lox;Foxn1Cre mice, 78% ± 1.1% in Raptorlox/lox;Foxn1Cre
mice and 84% ± 2.9% Rictorlox/loxRaptorlox/lox;Foxn1Cre mice were imma-
ture. The frequencies of immature CD8pos thymocytes were also significantly
increased in the Raptor and double mutant mice. Instead of 33% immature
SP among the CD8pos cells, TEC-directed loss of Raptor led to 42% ±
2.9% (*p < .05) and the combined inhibition of mTORC1 and mTORC2
in Rictorlox/loxRaptorlox/lox;Foxn1Cre mice led to 60% ± 3.8% (*p < .05)
immature CD8 SP thymocytes.
Given the changes in thymocyte cellularity and maturation in mTOR
mutant mice, I next investigated the peripheral T-cell compartment of these
animals. FACS analysis of splenic cell suspensions of 2 week old mice re-
vealed no significant changes in total splenocyte cellularity (Fig. 3.10). How-
ever, the frequencies of T-cells (marked by the surface expression of CD3
and the absence of CD19) were significantly diminished (Table in Fig. 3.10
B (iii)). The ratio of CD4pos to CD8pos remained unchanged in each of the
mutant mice. A closer look at the CD4 T-cell compartment revealed, how-
ever, that the distribution of na¨ıve T-cells (Tna¨ıve), memory T-cells (Tmem)
and regulatory T-cells (Treg) was differentially affected in the mutant mice.
To distinguish Tna¨ıve and Tmem from Treg, CD4
pos splenocytes were subdi-
vided according to their CD25 expression (Fig. 3.10 A) and CD25neg cells
were further differentiated as either na¨ıve (CD62Lpos) or memory T-cells
(CD44pos). In contrast, Treg were characterized based on their expression
of CD4, CD25, and intracellular FoxP3.
The frequency of Tna¨ıve and Tmem was only decreased in Rictor and
Raptor double mutant mice. Here, fewer na¨ıve T-cells could be discovered
from the spleen (34.2% ± 3.3% vs 88.1% ± 3.1% in wild type mice). In
parallel, the frequency of Tmem increased 7-fold (7.2% ± 2.4% in wild type
to 51.8% ± 0.8%) and that of Treg approximately 3-fold (6.8 % ± 0.4%
in wild type mice, 19.4% ± 1.9% in mutant mice). Thus, the pronounced
peripheral lymphopenia observed in Rictorlox/loxRaptorlox/lox;Foxn1Cre mice
can be ascribed to a substantial decrease in na¨ıve T-cells. Mice deficient
either in Raptor or Rictor expression in TEC had also fewer Treg, though
this decrease was less striking but still significant. The increase in Treg
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Figure 3.10: mTOR-deficiency in TEC leads to peripheral lymphopenia and to a
shift in the representation of peripheral T-cell subpopulations; (A) Gating scheme:
representative FACS plots from 2 week old wild type mice illustrate the gating strategy for the
characterization of splenic cells. DAPIpos cells and doublets have been excluded prior to analysis.
T-cells were characterized among total splenocytes by high surface-expression of CD3 and lack of
CD19. CD3pos cells were further subdivided according to the expression of either CD4 or CD8. To
discriminate na¨ıve (Tna¨ıve) and memory T-cells (Tmem) from regulatory T-cells (Treg), CD4
pos
splenocytes were further split based on the expression of CD25. CD25neg cells expressing CD62L
were classified as Tna¨ıve, whereas CD25
neg cells positive for CD44 were grouped as Tmem. To
identify Treg , CD4posCD25pos splenocytes were selected and analysed for Foxp3 expression. In
all mice analysed, the percentage of FoxP3 expressing cells among the CD4posCD25pos subset was
close to 100%. (B) Quantification of total splenic cells (i), frequencies of CD3hi cells presented in
bar graphs (ii) and in a table (iii), and frequencies of T-cell subpopulations (CD4pos and CD8pos
(iv);Treg , Tna¨ıve and T
men (v)); Values are indicated as means plus SD. (The number of mice
analysed per experiment is n = 10 for Rictorlox/lox mice, n = 8 for Raptorlox/lox mice, and n = 6
for Rictorlox/loxRaptorlox/lox mice; p values were determined by Student’s t test with *p < .05;
**p < .01; ***p < .005)
intensified with age and was proportional to the degree of lymphopenia.
Indeed, aged Raptorlox/lox;Foxn1Cremice showed a significant lymphopenia
due to a reduction in Tna¨ıve cells (Fig. 3.27).
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3.3 Detailed analysis of TEC and thymocyte de-
velopment in the absence of Raptor expression
in TEC
Next, Raptorlox/lox;Foxn1Cre mice were analysed in detail, as these animals
display a clear phenotype but still have sufficient thymic tissue for an in-
depth cellular and molecular analysis.
3.3.1 Thymic cellularity and architecture
First, I investigated thymi from Raptorlox/lox;Foxn1Cre mice and as controls
Raptorlox/lox mice at ages from one week to 35 weeks. Total thymic cellu-
larity was significantly diminished with age in Raptorlox/lox;Foxn1Cre mice,
reaching 30%–50% of the cellularity measured in wild type thymi (Fig. 3.11
A and B). This hypoplasia was accompanied by a reduced TEC cell count,
which was apparent as early as two weeks of age. TEC followed typical
age-dependent variations in cellularity, with increasing cell numbers from
postnatal stages until puberty and adulthood and a subsequent decrease at
advanced age. However, thymic hypoplasia in Raptorlox/lox;Foxn1Cre mice
of 1 week of age was not correlating with a reduction in total TEC. Within
the TEC compartment, impaired mTORC1 signalling had a different impact
on cTEC and mTEC. The absolute number of mTEC decreased substan-
tially in mice of two weeks and older, coinciding with the decrease in total
TEC. In contrast, the absolute number of cTEC remained unchanged in the
mutant mice when compared to age-matched controls. cTEC cellularity in
one and two week old mutant mice was even higher than that in wild type
animals. However, these changes in TEC numbers only became apparent in
the second week of life. Indeed, total thymic cellularity and TEC frequency
for both groups of animals were equal at embryonic day 15 and at birth
(Fig. 3.11).
The changes observed in the thymic epithelium were confirmed by im-
munohistology (Fig. 3.12). Although a distinct separation of the cTEC-
and mTEC-compartments was still appreciated in hematoxylin and eosin
stained sections of 7 week old female Raptorlox/lox and Raptorlox/lox;Foxn1Cre
mice, immunofluorescence staining of tissue sections showed distinct changes
within the thymi of mutant mice in comparison to wild type mice. A com-
bined staining for cytokeratin 5 (K5, typical for mTEC), cytokeratin 8 (K8,
a characteristic of cTEC) and the fibroblast-specific marker ERTR7 revealed
a loss in mTEC and a concomitant remodeling of the thymic stroma with
fibroblasts (Fig. 3.12 B). To ensure that the lack of K5-positive staining was
indeed the consequence of a loss of mTEC, we used in addition the mTEC-
specific marker MTS10. Both, MTS10 and K5 positive cells were strongly
reduced in Raptorlox/lox;Foxn1Cre mice, leaving only a few well demarcated
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Figure 3.11: Loss of mTORC1 in TEC results postnatally in thymic hypoplasia
with an absolute decrease of mTEC; (A) Representative photographs of thymi from E15
(i), newborn (ii), 1 weeks (iii), 7 weeks (iv) and 35 weeks (v) of Raptorlox/lox mice (left) and
Raptorlox/lox;Foxn1Cre mice (right). Scale bar represents 100 µm. (B) Thymus cellularity, TEC
cell count and total amount of cTEC and mTEC of Raptorlox/lox and Raptorlox/lox;Foxn1Cre
mice of different ages. Values are indicated as means plus SD. (For all experiments a minimum of
three mice per group were analysed. p values were determined by Student’s t test with *p < .05;
**p < .01; ***p < .005)
medullary islets in the thymic tissue of Raptor-deficient mice. Despite this
considerable reduction of mTEC, a distinct population of mature mTEC,
characterized by reactivity with Ulex europaeus agglutinin I (UEA1) and
the expression of the autoimmune regulator (AIRE), were detected in the
medulla (Fig. 3.12 B). Taken together, these data are suggestive of a re-
dundancy in mTORC1 mediated signalling during the prenatal stages of
development, and possibly the first week of life. They also demonstrate that
mTEC but not cTEC are susceptible to a loss of Raptor.
3.3.2 Early thymocyte development
Interactions between blood-borne precursor cells and thymic epithelia are
essential for the development of thymocytes. In view of the considerable
impact of mTORC1 inhibition on TEC numbers and phenotype, I next in-
vestigated the function of TEC in the absence of mTORC1. To exclude the
possibility that an altered thymocyte compartment in Raptorlox/lox;Foxn1Cre
mice was the result of changes in the bone marrow and thus in the generation
of haematopoietic T-cell precursors, mutant and wild type mice were inves-
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Figure 3.12: Alterations in the thymic microenvironment of Raptorlox/lox;Foxn1Cre
mice; (A) Hematoxylin and Eosin staining of thymic tissue sections (8 µm) of 7 week old fe-
male Raptorlox/lox mice (upper panel) and Raptorlox/lox;Foxn1Cre mice (lower panel). Scalebar
indicates 50µm. (B) Confocal microscopy of thymic tissue sections (8 µm) stained either for (i)
cytokeratin 8 (blue), cytokeratin 5 (green) and ERTR7 (red) or (ii) cytokeratin 8 (blue), cytoker-
atin 5 (green) and MTS10 (red) or (iii) cytokeratin 8 (green), UEA1 (blue) and AIRE (red). ”c”
denotes cortex, ”m” denotes medulla, white star marks large vessels. Dashed white line encircles
thymic medulla. Yellow boxed area within the medulla is shown in higher magnification. Scalebar
indicates 50µm.
tigated for the presence and frequency of these cells in the bone marrow
(Fig. 3.13). Lineageneg Sca1pos c-kithigh (LSK) cells expressing the lectin
CD62L, are the immediate pre-thymic T-cell precursor (Perry et al., 2004).
These cells were detected in Raptorlox/lox;Foxn1Cre mice at a normal fre-
quency. As expected, the loss of Raptor expression in TEC did thus not
exert any notable impact on the compartment of extrathymic T-cell precur-
sors.
Next, I analysed thymocyte development in Raptorlox/lox;Foxn1Cre mice
at one week, two weeks and seven weeks of age. Maturation-specific surface
markers were used to quantify thymocyte subpopulations of well-defined de-
velopmental stages. For this purpose, single cell suspensions from mutant
and wildtype thymi were stained for the expression of markers, expressed af-
ter commitment to a specific cell lineage (CD3, CD4, CD8, CD11b, CD11c,
CD19, B220, Gr1, Ter119, Nk1.1, Dx5, TCRα/β, TCRγ/δ and F4/80).
Cells, negative for any of these markers are typically termed ”Lineageneg”
and comprise the earliest thymocyte stages. Lineageneg cells were subse-
quently analysed for the cell surface expression of CD44 and CD25, which
allows a further differentiation of these cells into four subpopulations, des-
ignated DN1–DN4 (Fig. 3.14 A). Their frequencies were largely identical at
one week, two weeks and seven weeks of age. Although small differences in
the frequency of DN4 cells (at one week) and of DN2 cell (at seven weeks)
could be detected in the thymi of Raptorlox/lox;Foxn1Cre mice, these changes
were minimal and inconsistent over time (Fig. 3.14 B). The quantification
of the frequencies at all time points investigated did not reveal a block in
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Figure 3.13: Unperturbed frequencies of thymocyte progenitors in the bone marrow
of Raptorlox/lox;Foxn1Cre mice; Thymocyte progenitors within the bone marrow were analysed
by FACS and quantified. (A) Frequencies of Lineageneg Sca1pos c-kithigh (LSK) in the bone
marrow of Raptorlox/lox and Raptorlox/lox;Foxn1Cre mice. (B) Frequencies of CD62Lpos among
LSK in the bone marrow of Raptorlox/lox and Raptorlox/lox;Foxn1Cre mice. Values were indicated
as mean plus SD. Each experimental group consisted of 3 mice.
the maturational transition. To compare the maturational kinetics between
DN1–DN4 cells in Raptorlox/lox and Raptorlox/lox;Foxn1Cre thymi, mice were
injected with BrdU (1mg/mouse i.p.) and the label was “chased” after 4
hours. Similar frequencies of BrdU-labelled cells were recovered for the four
DN subsets of mutant and wild type mice, revealing identical kinetics in
the progression from one DN stage to the next (Fig. 3.14 C). These data
demonstrate that the loss of mTORC1 signalling in TEC did not impair the
earliest stages of intrathymic T-cell development.
3.3.3 Late thymocyte development
The transition from DP to SP cells depends on a close interaction between
the thymic epithelium and thymocytes, where only those cell are selected
to advance to a SP stage that express a TCR with a moderate affinity for
the self-complexes, presented usually by the medullary epithelia. Compar-
ative analysis of thymocytes from 1, 2 and 7 weeks old Raptorlox/lox mice
and Raptorlox/lox;Foxn1Cre mice, respectively, revealed also normal progres-
sion of intrathymic T-cell differentiation for the later stages of development
(Fig. 3.15). Although minimal differences in the relative frequency of the
different thymocyte subpopulations occur, these changes were not consis-
tent over time and limited in extent that their biological relevance has to
be questioned. (1week: CD8 0.6% ±0.08% in wild type vs. 0.4% ±0.04% in
Raptor-deficient mice, at 2 weeks DP 83.2% ±1.5% vs. 87.7% ±1.6% and
CD4 9.8% ±1.1% vs. 6.4% ±0.7%) However, Raptorlox/lox;Foxn1Cre mice
had significantly fewer thymocytes at any time point investigated.
A careful analysis of the post-selectional maturation of SP thymocytes
revealed a significant and continuous difference in the progression of T-cells
to full maturity, based on the cell surface expression of CD24 and CD69
(Fig. 3.16 A). SP CD4pos and CD8pos thymocytes are initially positive for
CD24 and CD69 and only downregulate their expression within a few days
of residency in the medulla (Yamashita et al., 1993). At the age of 1 week,
a mild, however not statistically significant increase in the relative repre-
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Figure 3.14: Unaltered early thymocyte development in Raptorlox/lox;Foxn1Cre mice;
(A) FACS plot of wild type mice illustrate gating strategy and definition of thymocyte subsets,
based on the absence of Lineage markers (CD3, CD4, CD8, CD11b, CD11c, CD19, B220, Dx5,
Nk1.1, Gr1, Ter119, F4/80, TCRα/β, TCRγ/δ), and the expression of c-kit, CD44 and CD25.
(B) Frequencies of double negative (DN) subpopulations DN1–DN4 among the Lineageneg cells
in the thymus of Raptorlox/lox and Raptorlox/lox;Foxn1Cre mice of the age indicated. Values
represent mean plus SD. The number of mice analysed per experiment is n = 4 (Raptorlox/lox
mice) and n = 4 (Raptorlox/lox;Foxn1Cre mice) at 1 week, n = 3 (Raptorlox/lox; mice) and
n = 5 (Raptorlox/lox;Foxn1Cre mice) at 2 weeks, and n = 4 (Raptorlox/lox mice) and n = 4
(Raptorlox/lox;Foxn1Cre mice) at 7 weeks. (C) Incorporation of BrdU after a 4 hours chase
(1mg/mouse i.p.). (i) Histograms for BrdU signal within the DN1–DN4 subset of 2 week old
Raptorlox/lox (black line) and Raptorlox/lox;Foxn1Cre mice (grey area). (ii) Frequencies of
BrdUpos thymocytes of the individual DN subsets shown as mean plus SD. (Per experimental
group. 4 mice have been analysed; p values were determined by Student’s t test with *p < .05;
**p < .01; ***p < .005)
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Figure 3.15: No block in the transition of DN to SP thymocytes in
Raptorlox/lox;Foxn1Cre mice; (A) Absolute number of thymocytes (DN–SP) within thymi
of Raptorlox/lox and Raptorlox/lox;Foxn1Cre mice of 1, 2 and 7 weeks of age determined by
flow cytometric analysis of surface expression of CD4 and CD8. (B) Relative frequencies of
DN, DP, CD4 SP and CD8 SP thymocytes at 1, 2, and 7 weeks of age. Values were indi-
cated as mean plus SD. The number of mice analysed per experiment is n = 4 (Raptorlox/lox
mice) and n = 4 (Raptorlox/lox;Foxn1Cre mice) at 1week, n = 3 (Raptorlox/lox; mice) and
n = 5 (Raptorlox/lox;Foxn1Cre mice) at 2 weeks, and n = 4 (Raptorlox/lox mice) and n = 4
(Raptorlox/lox;Foxn1Cre mice) at 7 weeks.
sentation of immature CD4pos and CD8pos thymocytes was observed with
69.5 % ±1.2% immature cells within the CD4 lineage in wild type mice and
72.2 % ± 3.6% in mutant mice and 32.2% ±3.7% immature cells within
the CD4 lineage in wild type and 37.0 % ±6.6% in Raptorlox/lox;Foxn1Cre
mice. At 2 weeks, the proportion of immature CD4pos thymocytes had sig-
nificantly increased from 67.3 % ±1.6% in wild type mice to 78.2% ±1.1%
(***p < .005) in mutant mice, and at 7 weeks from 64.0 % ±3.2% wild
type mice to 75.1% ±4.3% (**p < .01) in age-matched mutant mice. The
frequencies of immature SP cells within the CD8 lineage increased at 2
weeks from 32.9% ±3.4% in wild type to 42.6% ±2.9% (*p < .05) in mu-
tant mice and from 30.2% ±2.1% in wild type mice to 41.1% ±3.2% (**p
< .01) in Raptorlox/lox;Foxn1Cre mice at 7 weeks of age. Two possible ex-
planations may account for this increased frequency of immature SP cell in
Raptorlox/lox;Foxn1Cre mice. DP thymocytes undergo the transition to SP
thymocytes in a shorter time in comparison to wild type mice, or, alterna-
tively, fewer immature thymocytes get negatively selected before attaining
a mature SP phenotype. To investigate whether the observed overrepresen-
tation of immature SP thymocytes can be ascribed to a slower maturation
kinetic in the mutant mice, Raptorlox/lox and Raptorlox/lox;Foxn1Cre mice
were exposed to BrdU (1mg/mouse i.p.) and the labelling of SP thymocytes
was tested 4 days later. The frequencies of BrdUpos cells within the imma-
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Figure 3.16: Overrepresentation of immature SP in Raptorlox/lox;Foxn1Cre mice; (A)
(i) Flow cytometric analysis of CD4 (upper panel) and CD8 (lower panel) SP thymocytes based
on the expression of CD24 and CD69 at 7 weeks. To include only thymocytes that have been
positively selected, analysis included either CD4posCD3pos or CD8posCD3pos cells. Presence of
CD24 and CD69 was indicative of an immature SP phenotype. The mean relative frequency and
SD of the distinct subpopulations is provided on the respective gate. (ii) Comparison of the relative
frequency of CD4posCD24posCD69high (immature) thymocytes within the CD4 SP (upper graph)
and CD8posCD24posCD69high (immature) thymocytes within the CD8 SP cells (lower graph) in
Raptorlox/lox and Raptorlox/lox;Foxn1Cre mice of 1, 2 and 7 weeks. (B) (i) Histogram displaying
BrdU signal in CD4 and CD8 immature SP (i) or all CD4 and CD8 SP of Raptorlox/lox (black
line) and Raptorlox/lox;Foxn1Cre mice (grey area) after a 4 days pulse of BrdU (2x 1mg/mouse
within 4h). The mean relative frequency and SD of BrdUpos cells within CD4 and CD8 SP is
indicated on the respective histogram; Raptorlox/lox mice (black), Raptorlox/lox;Foxn1Cre (grey).
Values were indicated as mean plus SD. Each experimental group consisted of at least 3 mice. p
values were determined by Student’s t test with *p < .05; **p < .01; ***p < .005)
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ture CD4 and CD8 SP cells of Raptorlox/lox and Raptorlox/lox;Foxn1Cre mice
were identical for both strains of mice (Fig. 3.16 B (i), (ii)), thus excluded
an altered maturation kinetic during positive selection. These data indicate
that despite an altered microenvironment, thymi of Raptorlox/lox;Foxn1Cre
mice support DP to SP transition accurately.
In contrast to mature SP cells, immature SP thymocytes are subjected
to negative selection (Weinreich and Hogquist, 2008). Downregulation of
CD69, and therefore the development from an immature to a mature state,
represents a cell-intrinsic process within a defined time course of two to
three days (Yamashita et al., 1993). Thus, it is likely that an increase in the
frequency of immature SP thymocytes is caused by a less efficient elimination
of immature SP during negative selection. To address this question, RTOC
will be prepared from thymocyte-depleted E14 thymic lobes and mixed at
similar ratio with sorted immature CD4pos cells of Raptorlox/lox;Foxn1Cre and
of wild type mice (with CD45.1 congenital marker). If, indeed, autoreactive
T-cell clones contribute to the immature T-cell pool, the immuno-competent
wild type stroma will eliminate these cells, which will be reflected in an
altered ratio of wild-type to mutant-derived thymocytes.
3.3.4 Thymocyte egress
To examine a further explanation for the higher frequency of immature SP
thymocytes, thymocyte exit was investigated next in wild type and mu-
tant mice. Mature SP cells upregulate the expression of the sphingosine-1-
phosphate receptor (S1P1) on their cell surface, which is a prerequisite for
their egress. S1P1 binds to S1P released by neural crest-derived pericytes,
which are specialized cells ensheathing blood vessels. Detection of S1P1 on
mature thymocytes revealed that the relative frequency of S1P1 express-
ing mature CD4pos and CD8pos SP thymocytes was significantly reduced in
Raptorlox/lox;Foxn1Cre thymi compared to wild type (Fig. 3.17 A (i), (ii)).
Immunohistology further illustrated that thymi of Raptorlox/lox;Foxn1Cre
mice display a higher density of vasculature and an increased number of
pericytes in the medulla (Fig. 3.17 B), providing an indirect evidence for an
increased concentration of S1P in the medulla of mutant mice.
Together, these data suggest that an accelerated egress of mature SP
thymocytes in Raptorlox/lox;Foxn1Cre mice accounts additionally for the de-
crease in mature SP cells observed in mutant mice.
3.3.5 TEC differentiation and maintenance
TEC subpopulations
The separation of cTEC and mTEC into distinct maturational stages can
be further refined using additional cell surface and cytoplasmic markers.
Major histocompatibility complex class II molecules (MHCII) are commonly
61
S1P1
A (i) Raptorlox/lox
Raptorlox/lox;Foxn1Cre
72.1%
+/- 5.3
60.1%
+/- 2.8
72.3%
+/- 3.9
50.2%
+/- 2.1
* **
CD4mature
B
0
20
40
60
80
100
*
Fr
eq
eu
nc
y (
%
) w
ith
in 
CD
4p
os
S1P1pos
0
20
40
60
80
100
**
Fr
eq
eu
nc
y (
%
) w
ith
in 
CD
8p
os
S1P1pos
Raptorlox/lox
Raptorlox/lox;Foxn1Cre
(ii)
CD4mature
CD4immature
CD8mature
CD8mature
CD8immature
gated on the SP-subset indicated
Ra
pt
or
lox
/lo
x;F
ox
n1
Cr
e
CD4pos CD8pos
Ra
pt
or
lox
/lo
x
i ii iii
ii iii
m
c
i Vi
Vi
c
m
i
Figure 3.17: Mature SP thymocytes from Raptorlox/lox;Foxn1Cre express less S1P1;
(A) (i-ii) Representative histograms depicting S1P1 expression on mature CD4pos and CD8pos
thymocytes in wild type and mutant mice. S1P1 expression profile of immature SP thymocytes
of wild type mice were included (grey) to compare S1P expression intensities. The mean relative
frequencies and SD are indicated in a table and illustrated in bar graphs. p values were determined
by Student’s t test with *p < .05; **p < .01; ***p < .005). (B) Confocal microscopy of thymic
tissue sections (8 µm) stained for DAPI, panKeratin (blue), CD31 (green) and Ng2 (red). Stainings
were shown separately for selective colors; DAPI (I), merge of all colors (panKeratin, CD31 and
Ng2) (II), CD31 (III) and Ng2 (IV). ”c” denotes cortex, ”m” denotes medulla, white arrow heads
mark pericytes. Dashed white line encircles thymic medulla. Scalebar indicates 50µm.
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Figure 3.18: Phenotypical characterization of raptor-deficient TEC over time in com-
parison the wild type TEC; (A) (i) FACS plots of TEC (CD45negEpCAMpos) of Raptorlox/lox
(black) and Raptorlox/lox;Foxn1Cre mice (grey), showing the representation of cTEC
(CD45negEpCAMposLy51posUEA1neg) and mTEC (CD45negEpCAMposLy51negUEA1pos)
within the TEC compartment at 2 weeks of age. Percentages indicated on the plots are dis-
playing the mean frequency of the TEC subpopulation (cTEC in the upper right and mTEC in
the lower left corner) ± SD. Frequencies (i) and absolute number (ii) of mTEC in Raptorlox/lox
and Raptorlox/lox;Foxn1Cre mice at the time points indicated. (B) Histogram overlays of TEC, or
cTEC and mTEC, respectively from 2 weeks (i) or 35 weeks (ii) old Raptorlox/lox (black line) and
Raptorlox/lox;Foxn1Cre mice (grey area). Values next to the histogram indicate the frequencies
of MHCIIhi cell as mean plus ± SD. (iii) Frequencies of MHCIIhi expressing cells within mTEC
(upper graph) and cTEC (lower graph) in Raptorlox/lox and Raptorlox/lox;Foxn1Cre mice of dif-
ferent ages. (C) Histogram overlays gated in MHCIIhi mTEC of Raptorlox/lox (black line) and
Raptorlox/lox;Foxn1Cre mice (grey area) at 2 weeks (i) and 35 weeks (ii) of age. Values next to
the histogram indicate the frequencies of AIREpos cells within the MHCIIhi mTEC as mean plus
± SD. (iii) Frequency of AIREpos cells within the MHCIIhi mTEC observed in Raptorlox/lox and
Raptorlox/lox;Foxn1Cre mice from newborn (Nb) to 35 weeks of age. Each experimental group
consisted of at least 3 mice. p values were determined by Student’s t test with *p < .05; **p <
.01; ***p < .005)
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expressed on all TEC lineages, either to low or high degrees. mTEC that
express low cell surface MHCII (designated mTEClo) are deemed immature,
whereas MHCII high-expressing mTEC (mTEChi) are mature (Gray et al.,
2007, 2006). To investigate whether the absence of Raptor reduced not
only the relative and absolute number of mTEC (Fig. 3.18 A) but also
impacted on their differentiation, I next determined the MHCII cell surface
expression on TEC from Raptor-deficient and wild type mice of different
ages (Fig. 3.18 B). There was a non-significant difference at 2 weeks and a
significant change at 35 weeks of age. At the latter time point, MHCIIhi TEC
made up for 62.8% ±3.9% of all TEC in the mutant mice in comparison to
the controls (45.1% ±2.8%; **p < .01) (Fig. 3.18 B(ii)). This regulation was
next investigated separately for cTEC and mTEC. In 2 weeks old mutant
mice, the frequency of MHCIIhi cTEC was similar to the values in wild
type mice (33.2% ±2.8% in wild type mice vs. 29.9% ±3.3% in mutant
mice)(Fig. 3.18 B(i)). In mice of this age, only mTEC with a MHCIIhi
phenotype were significantly overrepresented in the Raptor-deficient animals
when compared to age-matched wild type mice (60.8% ±0.8% in wild type
mice vs. 69.3% ±4.3% in mutant mice; *p < .05). In 35 week old mutant
mice, the difference in the frequency of MHCIIhi mTEC in Raptor-deficient
mice was even higher than at 2 weeks (49.4% ±1.9% in wild type mice vs.
69.5% ±2.4% in mutant mice; ***p < .005), and the increase in MHCIIhi
cTEC in Raptor-deficient mice became significant (34.1%±6.4% in wild type
vs. 55.9% ±5.1% in mutant mice; *p < .05). The comparison of the MHCII
expression on cTEC and mTEC of wild type and mutant mice between
newborn age and 35 weeks revealed that mTEC of Raptorlox/lox;Foxn1Cre
mice displayed already from the age of 1 weeks a significant increase in
MHCIIhi expressing cells. In contrast, MHCIIhi cTEC were significantly
overrepresented from 3 weeks of age onwards (Fig. 3.18 B(iii)). These data
suggest that the medullary expression of MHCII is much earlier affected in
the absence of raptor than on cTEC.
Another marker attributed to maturity of mTEC is the Autoimmune reg-
ulator (AIRE), which has been found to be exclusively expressed in MHCIIhi
mTEC (Gray et al., 2007; Derbinski et al., 2005) and was described to be
associated with a post-mitotic, terminally differentiated TEC (Kyewski and
Klein, 2006). The proportion of AIREpos mTEC was increased in mutant
mice, a change which became significant at 3 weeks of age (58% ±1.6%
in wild type mice vs. 70.2% ±5.3% in Raptorlox/lox;Foxn1Cre mice; *p <
.05)(Fig. 3.18 C (i), (ii, (iii)). This significant difference in AIREpos cells
increased continuously (8.5% at 3weeks, 16.8% at 35 weeks).
A subclassification of cTEC subpopulations by FACS has recently been
proposed (Shakib et al., 2009) and takes advantage of a differential CD40
expression with immature cTEC lacking this co-stimulatory ligand, whereas
mature cTEC express this molecule. The comparison of Raptorlox/lox and
Raptorlox/lox;Foxn1Cre mice 2 weeks and 35 weeks of age for the presence
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Figure 3.19: Lack of CD40 expression in cTEC of Raptorlox/lox;Foxn1Cre mice;
(A) (i) histogram overlays depicting the expression of CD40 in cTEC of Raptorlox/lox and
Raptorlox/lox;Foxn1Cre mice at 2 and 35 weeks. (ii) FACS plots illustrating the relation of CD40
expression and size (FSC) in cTEC of Raptorlox/lox and Raptorlox/lox;Foxn1Cre mice at 2 and
35 weeks. Each experimental group consisted of at least 3 mice. p values were determined by
Student’s t test with *p < .05; **p < .01; ***p < .005)
of CD40 on cTEC demonstrated that these mature cortical epithelia were
largely missing in the mutant mice at each time point investigated (Fig. 3.19
A (i)). Moreover, a correlation between TEC size and CD40 expression
levels was observed (Fig. 3.19 A (ii)), which suggests that Raptor-deficiency
impacts on one or both parameters.
Thymic nurse cells
Within the thymic microenvironment, specialized cTEC have been identified
that completely embody various numbers of developing thymocytes. Termed
“nurse cells” (Wekerle and Ketelsen, 1980; Kyewski et al., 1981; Hirokawa
et al., 1986), these cells are thought to optimize the process of positive T-
cell selection (Nakagawa et al., 2012). To visualize these nurse cells, TEC
were sorted and subsequently placed on a glass slide (cytospin). Closed cell
complexes were then detected by light microscopy (Fig. 3.20A). To charac-
terize the cells captured by the nurse cells in more detail, the cell complexes
were stained for DAPI, CD45, keratin 5 and 8 (Fig. 3.20 B). The analy-
sis revealed numerous hematopoietic cells (CD45pos, DAPI pos) captured by
cortical TEC (K8pos). At present, the specific stages of thymocytes nursed
by cTEC have not yet been determined.
To investigate whether the lack of mTORC1 signalling in TEC has an
impact on the ability of cTEC to form nurse cell complexes, thymic cell
suspension of wild type and Raptorlox/lox;Foxn1Cre mice were quantified by
FACS (Fig. 3.21 A). Wild type mice displayed 11.4% nurse cells within the
cTEC compartment. In contrast, cTEC of Raptorlox/lox;Foxn1Cre mice dis-
played only about 4% nurse cells. The correct gating was confirmed by com-
parison of SSC/FSC profiles of nurse cells and TEC in both mouse strains
(Fig. 3.21 B). From these data, it can be concluded that less thymic nurse
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A B Figure 3.20: Characterization
of thymic nurse cells; (A) Light
microscopic picture of a thymic
nurse cell, located on a cytospin of
sorted TEC (CD45negEpCAMpos)
of a wild type mouse. Confocal
microscopic picture (B) of thymic
nurse cell, stained for DAPI (i), K8
(ii), CD45 (iii) and K5 (iv). Scale-
bar indicates 50µm.
cells can be found in thymi composed of raptor-deficient TEC compared to
wild type.
3.3.6 Chemokinetic function of TEC
To orchestrate the complex process of T-cell precursor attraction, thymo-
cyte maturation and emigration, signals are in place that emanate from the
thymic stroma and control these processes. TEC represent the main source
of chemo-attractants enabling heamatopoietic precursor cells to continuously
colonize the thymus. There was a direct correlation between total thymic
cellularity and the total number of early thymic precursors (ETP) within
the thymi of Raptorlox/lox; and Raptorlox/lox;Foxn1Cre mice. This implies
that the number of thymocyte precursors that enter the thymus is eventu-
ally shaping the size of the thymus (Fig. 3.22 A). Raptor-mutant mice had
fewer ETP (vs. in wild type mice) both when compared to thymus cellular-
ity and to the number of TEC (Fig. 3.22 B (i), (ii), (iii)), though the latter
correlation was only observed in mice older than 2 weeks of age (Fig. 3.22
B (i)). Taken together, these data strongly indicate that the loss of Raptor
expression in TEC results in a qualitative change that impairs the attraction
of T-cell precursors.
Next, I assessed the expression of chemokines in TEC using qPCR. Previ-
ous analysis revealed the presence of nurse-cell-thymocyte complexes within
the cTEC compartment. Therefore, chemokine-transcript levels of cTEC
were normalized to EpCAM, whose expression was shown to be indepen-
dent of Raptor (Fig. 3.22 C (i)).
In a first experiment, the main cellular source for chemoattractants was
identified. For this purpose, chemokine transcript levels of sorted wild-type
cTEC and mTEC were compared to transcript levels detected in unsorted
total thymic cells. In wild type mice, Cxcl12 and Ccl25 were abundantly
expressed in cTEC, whereas transcripts for Ccl19 and Ccl21 were typically
detected in mTEC (Fig. 3.22 C (ii)). In the absence of Raptor expression,
the levels of all chemokine transcripts were decreased in cTEC, with the
exception of Ccl21. The identical analysis in mTEC demonstrated that
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Figure 3.21: Raptorlox/lox;Foxn1Cre mice display less thymic nurse cells; (A) FACS
plots of Raptorlox/lox mice (black) and Raptorlox/lox;Foxn1Cre mice (grey) illustrating gate-
and staining strategy. cTEC, discriminated by surface staining for CD45, EpCAM, Ly51 and
UEA1 as CD45negEpCAMposLy51posUEA1negcells, were sorted and intracellularly stained for
CD45. Using different dyes conjugated to CD45, cell surface and intracellular CD45 staining
could be discriminated. The re-stained cTEC were re-analysed by FACS. The percentage of
intracellular (ic) CD45posEpCAMpos re-analysed cTEC is indicated as percentage in the upper
right quadrant of then FACS plot. Orange and red boxed areas are referring to the backgate
analysis depicted in (B). Backgate analysis of Side Scatter (SSC) and Forward Scatter (FSC)
illustrate the size of cTEC CD45pos (orange box) and cTEC CD45neg (red box) of Raptorlox/lox
mice and Raptorlox/lox;Foxn1Cre mice.
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the Ccl21 transcripts were unchanged, whereas those for Cxcl12 were sig-
nificantly decreased, and those for Ccl19 and Ccl25 mildly increased. IL-7
transcripts were halved in cTEC from Raptorlox/lox;Foxn1Cre mice. Raptor-
deficient mTEC produced about twice as many IL-7 transcripts compared
to wild type mTEC. Taken together, mTORC1 signalling-deficient TEC are
impaired in the transcription of factors necessary to attract T-cell precur-
sors to the thymic microenvironment (Cxcl12, Ccl19, Ccl25) and to promote
their survival in situ (IL-7).
3.3.7 TEC size
The size of an organ is regulated by two individual parameters, namely the
number of cells and their size. A lack of mTORC1-signalling in TEC sig-
nificantly reduced thymic size and this decrease correlated with an overall
reduction in absolute cell number. An inhibition of mTORC1 has also been
associated with a reduction of cell size. The precise mechanism remains,
however, poorly understood (Fingar et al., 2004; Fumarola et al., 2005).
In drosophila, the mTOR homolog dTOR is cell autonomously required for
normal cell growth during larval development (Zhang et al., 2000). A loss-of-
function mutant of dTOR results in substantial decrease in both, cell number
and cell size. To investigate, whether the inhibition of mTORC1 signalling
in TEC also influences cellular size, TEC were assessed by light microscopy
and FACS for their size (Fig. 3.23 A, B). For this purpose, sorted TEC of
Raptorlox/lox and Raptorlox/lox;Foxn1Cre mice were cytospun and stained for
hematoxylin and eosin. Light microscopy revealed Raptor-deficient TEC
to be smaller than TEC of wild type animals (Fig. 3.23 A). However, due
to the exposure to fixatives and high centrifugal forces during spinning,
preparation-associated artifacts could not be excluded as a cause for the ob-
served differences. For an independent and likely more reliable measurement
of sizes, the mean fluorescence intensities (MFI) of the TEC forward scatter
(FSC) was determined, using flow cytometry (Fig. 3.23 B (i), (ii)). TEC size
was identical for mutant and wild type TEC at prenatal stages. A decrease
in TEC size was observed in postnatal TEC of Raptorlox/lox;Foxn1Cre mice
(Fig. 3.23 B (i)). In view of the heterogenous composition of the TEC com-
partment in general and the genotype-related overrepresentation of specific
TEC subpopulations in particular, the cell size of cTEC and mTEC from
mutant mice were separately analysed (Fig. 3.23 B (ii)). To quantify the cell
size reduction, cTEC and mTEC sizes of Raptorlox/lox;Foxn1Cre mice were
compared to that of the respective TEC subpopulations in wild type mice.
Statistical analysis revealed a reduction of TEC size of about 10% in the
mutant mice of one week and older. This reduction was marginally more
pronounced for cTEC. Because cell size varies during cell cycle, cell size
of mTORC1-sufficient and -deficient TEC was determined in relation to the
stage within the cell cycle. TEC size was reduced in all stages of the cell cycle
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Figure 3.22: TEC of Raptorlox/lox;Foxn1Cre mice have impaired capacity of precur-
sor attraction; (A) Correlation between number of total ETP and total thymic cellularity in
Raptorlox/lox; (white circle) and Raptorlox/lox;Foxn1Cre mice (grey circle). (B) Total cellularity
of TEC (i) and ETP (ii) in Raptorlox/lox; and Raptorlox/lox;Foxn1Cre mice. Values were indicated
as mean plus SD. Each experimental group consisted of at least 3 mice. p values were determined
by Student’s t test with *p < .05; **p < .01; ***p < .005) (iii) Ratio of the mean absolute num-
ber of ETPs to the mean absolute number of TEC in Raptorlox/lox; and Raptorlox/lox;Foxn1Cre
mice. (C) Result of qPCR analysis of sorted cTEC and mTEC. (i) Amount of EpCAM transcript
present in sorted cTEC of Raptorlox/lox;Foxn1Cre mice normalized to values found in sorted cTEC
of Raptorlox/lox; mice. (ii) Fold change of various transcripts in sorted cTEC (light grey) and
mTEC (dark grey) of Raptorlox/lox;Foxn1Cre mice compared to total wild type thymus. Fold
change of transcripts in cTEC (iii) and mTEC (iv) of Raptorlox/lox;Foxn1Cre mice compared to
Raptorlox/lox; mice. Values are means of at least three independent experiments; indicated plus
SD. p values were determined by Student’s t test with *p < .05; **p < .01; ***p < .005)
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(A) Hematoxylin Eosin staining of sorted TEC (CD45negEpCAMpos) of adult Raptorlox/lox
and Raptorlox/lox;Foxn1Cre mice. Scale bar indicates 50 µm. (B) (i) FACS histogram over-
lays, displaying the forwards scatter (FCS) of TEC at gestational day 15 and at 7 weeks of
age in Raptorlox/lox (black line) and Raptorlox/lox;Foxn1Cre mice (grey area). (ii) Comparison
of the mean fluorescence intensity (MFI) for the FCS of Raptor-sufficient and Raptor-deficient
cTEC (dark grey) and mTEC (light grey) at the ages indicated. Mean values for the size of
Raptor-deficient cTEC and mTEC were normalized to values evaluated from the respective TEC
subpopulation in wild type TEC. (C) (i) FACS histogram overlays, comparing the sizes of TEC
originating from Raptorlox/lox (black line) or Raptorlox/lox;Foxn1Cre mice (grey area) at differ-
ent stages of the cell cycle. Cell cycle phases were determined by PI staining. (ii) Comparison
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in the absence of Raptor with the largest impact observed for cells residing
in G0/G1-phase and the smallest changes noted for the S-phase. This result
is in agreement with in vitro studies analysing Jurkat cells treated with the
mTOR-inhibitor Rapamycin (Fingar et al., 2004). Thus, Raptor expression
in TEC determines cell size, and its absence correlates with a smaller cell
volume at any stage of the cell cycle.
3.3.8 TEC cell cycle
The inhibition of mTOR-signalling impairs proliferation. Therefore, I next
investigated, whether thymic hypoplasia observed in Raptorlox/lox;Foxn1Cre
mice was related to reduced TEC proliferation. For this purpose, Raptorlox/lox
and Raptorlox/lox;Foxn1Cre mice were injected with BrdU (1mg/mouse i.p.)
and the incorporation of label was analysed 4 hours later. At the age of 2
days, the absolute number of BrdUpos cTEC and mTEC were identical to
that of age-matched controls (Fig. 3.24). However, a significant reduction
in spontaneous cell proliferation was revealed in 1 and 3 week old mutant
mTEC (Fig. 3.11 A and B). In contrast, the cell proliferation of cTEC was
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Figure 3.24: TEC of in Raptorlox/lox;Foxn1Cre mice proliferate less than TEC of age-
matched Raptorlox/lox mice measured by incorporation of BrdU; Raptorlox/lox and
Raptorlox/lox;Foxn1Cre mice of different ages were injected with 1mg BrdU/m use 4h prior to
analysis.(A) Frequency of BrdUpos cTEC (i) and mTEC (ii) at the time points indicated. Values
were indicated as mean plus SD. Each experimental group consisted of at least 3 mice. p values
were determined by Student’s t test with *p < .05; **p < .01; ***p < .005)
not impaired due to the absence of Raptor. This latter finding is in line with
the observation that cTEC in Raptorlox/lox;Foxn1Cre mice and Raptorlox/lox
mice have identical cTEC numbers. Taken together, mTORC1 signalling
is essential for the proliferation of mTEC, providing an explanation for the
particular reduction of mTEC in Raptorlox/lox;Foxn1Cre mice.
3.3.9 TEC response to acute stress
Changes in organ cellularity can generally be attributed to differences in
either cell proliferation and/or in cell death. To address changed suscepti-
bility for programmed cell death between TEC with a functional or a non-
functional mTORC1 signalling, respectively, the presence of cleaved cas-
pases and Terminal deoxynucleotidyl transferase dUTP nick end labeling
(TUNEL) were sought by flow cytometry. Since this analysis requires a cell
isolation step, during which the TEC are exposed to enzymes and mechan-
ical stress, the presence of activated caspases was reflective of the general
capacity of TEC to cope with acute cell stress. First, the influence of mTOR
signalling on TEC viability was assessed. For this purpose, TEC from 2 days
old mice — representative for a time point before the ablation of Raptor re-
sults in a discernible phenotype — and 3 weeks old mice were analysed. The
activation of caspases was indistinguishable between 1 week old mutant and
wild type mice. However, a significant difference was observed in 3 weeks old
animals as 62.5% ±4.2% CaspACEpos cells were recovered in Raptorlox/lox
mice and 42.6% ±1.9% CaspACEpos TEC from Raptorlox/lox;Foxn1Cre mice
(*p < .05) (Fig. 3.25) A (i), (ii)).
To exclude the possibility that differences in thymus size influenced the
accessibility of TEC and therefore facilitated the digest procedure, an addi-
tional control experiment was carried out isolating TEC from a compa-
rable thymus “cell mass” (i.e. one Raptorlox/lox thymus and a pool of
three Raptorlox/lox;Foxn1Cre thymi were prepared in parallel). The differ-
ences seen in the previous experiments continued to be observed between
Raptorlox/lox and Raptorlox/lox;Foxn1Cre mice, with TEC lacking Raptor dis-
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Figure 3.25: TEC of Raptorlox/lox;Foxn1Cre mice are less susceptible to stress-induced
apoptosis than wild type TEC; (A) (i) Histogam overlay for CaspACE signal in TEC of 3
week old Raptorlox/lox (black line) and Raptorlox/lox;Foxn1Cre mice (grey area). To exclude
dead cells from the analysis, only DAPIneg cell were analysed. The percentages indicated on the
FACS plot represent the mean values of CaspACEpos cells within TEC ± SD. (ii) Comparison
of the frequency of CaspACEpos TEC among Raptor-sufficient and Raptor-deficient TEC after
a routine TEC isolation procedure. Values were indicated as mean plus SD. Each experimental
group consisted of at least 3 mice. p values were determined by Student’s t test with *p <
.05; **p < .01; ***p < .005)(iii) Values were indicated as mean plus SD. (iii) Comparison of
the frequency of CaspACEpos TEC among Raptor-sufficient and Raptor-deficient TEC after a
routine TEC isolation procedure starting with an approximately similar number of thymic cells for
isolation. (B) Histogram overlay displaying TUNELpos cells among TEC (i), or cTEC and mTEC
(ii) of Raptorlox/lox (black line) and Raptorlox/lox;Foxn1Cre mice (grey area). The percentages
indicated on the FACS plot represent the mean values of TUNELpos cell within TEC ± SD.
playing a higher resistance to cell stress.
Next, a TUNEL-staining of mutant and wild type TEC was performed,
in order to assess apoptosis and cell death not only by detection of activated
caspases, which occur very early after cell damage, but also by analysis
of substrates generated at the end of the apoptotic signalling cascade, like
DNA fragments. TUNEL-positivity was observed in 3.9% of TEC from
Raptorlox/lox and 2.2% TEC from Raptorlox/lox;Foxn1Cre mice (Fig. 3.25 B
(i)). This difference held up when analysing cTEC and mTEC separately:
(3.34% mTEC in wild type and 1.87% mTEC in Raptorlox/lox;Foxn1Cre mice
were TUNEL positive, while 10.2% cTEC in wild type and 1.5% cTEC in
Raptorlox/lox;Foxn1Cre mice were detected (Fig. 3.25) B (ii)).
These data have shown Raptor-deficient TEC to be less susceptible to
acute stress and apoptosis than TEC of wild type littermates, arguing
against the hypothesis that thymic hypoplasia might be attributed to an
increase in TEC cell death (Fig. 3.25 A (iii)).
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Figure 3.26: Autophagic activity is highest in MHCIIhigh cTEC, but unaltered in
the presence or absence of Raptor protein in TEC; FACS analysis of autophagy in TEC
and TEC subsets. (A) (i) FACS plots illustrating the relation between MHCII expression and au-
tophagic activity in TEC (CD45negEpCAMpos) cTEC (CD45negEpCAMposUEA1negLy51pos)
and mTEC (CD45negEpCAMposUEA1posLy51neg) of adult (7w) Raptorlox/lox (black) and
Raptorlox/lox;Foxn1Cre mice (grey). (ii) Histogram overlays for autophagic activity of TEC, or
cTEC and mTEC, respectively of Raptorlox/lox (black) and Raptorlox/lox;Foxn1Cre mice (grey).
Autophagic activity of MHCIIhigh or MHCIIlow cTEC or mTEC is indicated as dotted line in
either black (Raptorlox/lox) or grey (Raptorlox/lox;Foxn1Cre). Unstained control TEC are repre-
sented by a blue line, stained thymocytes by a red line.
3.3.10 Autophagy in TEC
mTOR is a negative regulator of cellular autophagy (Nazio et al., 2013).
Therefore, the autophagic activity of Raptor-deficient and Raptor-proficient
TEC was compared. Using a dye that selectively labels autophagic vacuoles,
such as pre-autophagosomes, autophagosomes, and autolysosomes, the au-
tophagic flux was measured.
To increase the number of cells and therefore the reliability of the anal-
ysis, thymi from 7 weeks old Raptorlox/lox and Raptorlox/lox;Foxn1Cre mice,
respectively, were pooled for the following investigations.
In contrast to most cells, TEC display already very high basal activity
of autophagy, which is linked to their generation of peptide/MHC class II
ligands and their role as antigen presenting cells. The analysis included
as controls unstained TEC and stained thymocytes to test the specificity
and significance of the signals observed with staining of autophagic vac-
uoles in TEC. The autophagy signal was higher in mature TEC and more
prounced in the cortial epithelia in comparison to medullary TEC (3.26 A
(i)). Autophagy was increased in both, wild type and mutant TEC when
compared to that in thymocytes, but did not differ between Raptor-sufficient
and Raptor-deficient epithelia (3.26 A (ii)). On closer examination, a dis-
tinct “shoulder” in the histogram of cTEC from mutant mice was observed
in comparison to corresponding epithelia from wild type mice, suggesting
a possible higher autophagy in the former cells. Further analysis revealed,
however, that both mature and immature cTEC displayed the same degree
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of autophagy. Thus, the overrepresentation of MHCIIhi expressing cTEC
in Raptorlox/lox;Foxn1Cre likely accounts for the mild difference in signal ob-
served when analysing unseparated cTEC.
3.4 Peripheral T-cell function in mice deficient for
Raptor expression in TEC
Thymi from Raptorlox/lox;Foxn1Cre mice older than 1 week of age are lym-
phopenic. To test how this influenced the peripheral T-cell compartment,
the spleen and lymphnodes of mutant and control mice were next inves-
tigated. A significant decrease regarding the absolute number of CD4pos
and CD8 pos splenocytes was discernible in Raptorlox/lox;Foxn1Cre mice from
1 week onwards. In 35 weeks old mice, the total number of T-cells was com-
parable for both types of mice analysed (Fig. 3.27 A (i),(ii)). The frequencies
of CD4pos and CD8 pos splenocytes, however, were at all investigated time
points identical in Raptorlox/lox and Raptorlox/lox;Foxn1Cre mice (Fig. 3.27
B (i),(ii)).
A closer look at the CD4pos T-cell compartment revealed a shifted rep-
resentation of the CD4pos subpopulations in mutant mice when compared to
wild type mice (Fig. 3.27 B (iii)–(v)). Raptorlox/lox;Foxn1Cre mice displayed
a significant reduction in the frequency of na¨ıve T-cells (Tna¨ıve) at 7 weeks
of age and older (78.3% ±3% in wild type mice and 58.1% ±9.3% in mutant
mice; ***p < .005). In contrast, regulatory T-cells (Treg) and memory T-
cells (Tmem) from mutant mice were overrepresented when compared to wild
type mice at the age of 2 weeks or 7 weeks, respectively, and older (7.5%
±0.4% Treg in 7 weeks old wild type mice vs. 10.4% ±0.7% in mutant mice
(***p < .005); and 21.7% ±3.0% Tmem in 7 week old wild type mice vs.
41.8% ±9.3% in mutant mice; (*p < .05)). These data show that Raptor
ablation in TEC influences the number and phenotype of peripheral T-cells.
3.4.1 V-beta repertoire
Changes in the selection of immature thymocytes and peripheral T-cell
lymphopenia can influence TCR Vβ-usage. Therefore, the TCR repertoire
of thymocytes and lymphocytes of Raptorlox/lox and Raptorlox/lox;Foxn1Cre
mice was investigated. As the relative frequency of the individual T-cell sub-
populations varied in wild type and mutant mice, the different T-cell subsets
(CD4pos Treg, Tmem, Tna¨ıve, and CD8
pos T-cells) were analysed separately.
The frequencies for all 16 TCR Vβ families were comparable in all T-cell
subsets (Fig. 3.28 A, B). Hence, Raptor-deficiency in TEC is compatible
with the development of a polyclonal T-cell repertoire, though it remains to
be determined whether this function is altered in older mice.
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Figure 3.27: Peripheral lymphopenia in Raptorlox/lox;Foxn1Cre mice with alterations
in the representation of T-cell subsets; (A) Absolute number of CD4pos (i) and CD8pos T-
cells (ii), Treg (CD4pos, CD25pos, FoxP3pos)(iii), Tmem (CD4pos, CD44high, CD62Lneg) (iv)
and Tna¨ıve (CD4
pos, CD44low, CD62Lpos) (v) in the spleen of 1–35 weeks old Raptorlox/lox
mice and Raptorlox/lox;Foxn1Cre mice. (B) Frequencies of CD4pos (i) and CD8pos T-cells
(ii), Treg (CD4pos, CD25pos, FoxP3pos)(iii), Tmem (CD4pos, CD44high, CD62Lneg) (iv) and
Tna¨ıve (CD4
pos, CD44low, CD62Lpos) (v) in the spleen of 1–35 weeks old Raptorlox/lox mice and
Raptorlox/lox;Foxn1Cre mice. Values were indicated as mean plus SD. Each experimental group
consisted of at least 3 mice. p values were determined by Student’s t test with *p < .05; **p <
.01; ***p < .005)
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Figure 3.28: Equal frequencies of usage of the TCR vβ-chains of na¨ıve CD4pos and
CD8pos T-cells in Raptorlox/lox and Raptorlox/lox;Foxn1Cre mice; Usage of the TCR Vβ-
chains of na¨ıve CD4pos and CD8pos in thymus (A) and lymphnodes (B). Values were indicated
as mean plus SD. Each experimental group consisted of at least 3 mice. p values were determined
by Student’s t test with *p < .05; **p < .01; ***p < .005)
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Figure 3.29: T-cells derived from Raptorlox/lox;Foxn1Cre mice show identical capabil-
ity to proliferate secondary to TCR- stimulation in vitro as wild type T-cells; (A) CFSE
profiles illustrating the proliferation of sorted na¨ıve CD4 (i) and CD8 (ii) lymphocytes from wild
type and mutant mice after three days in culture in the presence of α-CD3 at the concentrations
indicated. Co-stimulation was provided from irradiated RAG-/- splenocytes. (B) Bar graphs dis-
playing the proliferative index of sorted na¨ıve CD4 (i) and CD8 (ii) lymphocytes after stimulation
calculated by FlowJo Software. Values were indicated as mean plus SD. Each experimental group
consisted of at least 3 mice. p values were determined by Student’s t test with *p < .05; **p <
.01; ***p < .005)
3.4.2 In vitro activation of na¨ıve T-cells
The function of the T-cells selected in the thymus of Raptorlox/lox;Foxn1Cre
mice was next investigated. For this purpose, purified Tna¨ıve CD4
pos or
CD8pos T-cells from Raptorlox/lox and Raptorlox/lox;Foxn1Cre mice were cul-
tured for 3 days in the presence of different α-CD3 concentrations (0 to
1µg/ml) and lethally irradiated splenocytes from recombination activating
gene 2 (RAG2) deficient mice as a source of co-stimulatory molecules. The
cell proliferation was determined by labeling the sorted na¨ıve T cells with
carboxyfluorescein succinimidylester (CFSE). With rising α-CD3 concen-
trations, both CD4pos and CD8pos na¨ıve T cells from Raptor-deficient and
-proficient mice showed similar increased proliferative responses (Fig. 3.29 A
and B). Thus, na¨ıve T-cells generated in the thymus in the presence of TEC
lacking Raptor react normally to CD3 stimuli when compared to wild type
controls, as reflected by identical CFSE profiles and proliferative indices.
3.4.3 In vivo activation of na¨ıve T-cells
To finally assess the in vivo competence of T-cells generated in either wild
type or Raptorlox/lox;Foxn1Cre mice, sorted na¨ıve CD4
pos T-cells were adop-
tively transferred to RAG2 -/- mice. The ability of transferred na¨ıve T-cells
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to mount an immune reaction against the gut flora in lymphocyte-deficient
mice RAG2-/- mice can be used to gauge their competence to react to anti-
gens. The induction of wasting disease was defined as end point of the
experiment. With an average survival of 35 days ±19 days in wild type
and 30 days ±8 days in mutant mice, no obvious difference in the poten-
tial to react in vivo against antigens could be observed between Tna¨ıve cells
originating from a wild type thymus or a thymus that lacked mTOCR1 sig-
nalling in its epithelium (Fig. 3.29 A (i)). To evaluate the reliability of this
outcome, the experimental setup was repeated, however this time not with
2 x 105 but 4 x 105 Tna¨ıve cells transplanted. With an average survival of 50
days ±18 days in wild type mice and 44.5 days ± 9 days in RAG-/- mice,
the induction was less efficient but revealed no difference in the survival of
RAG-/- mice according to the origin of the cells transferred (Fig. 3.29 A
(ii)).
This finding indicates that Tna¨ıve cells generated in a thymus composed
of Raptor-deficient TEC show an identical potential to mount an immune-
response as Tna¨ıve cells of wild type mice.
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Figure 3.30: Induction of wasting
disease in RAG2-/-; Evaluation of
T-cells to induce wasting disease after
adoptive transfer into RAG2-/- recipi-
ents. (A) Survival curve after transplan-
tation of 200,000 (i) or 400,000 (ii) sorted
Tna¨ıve cells (CD4
posCD44negCD62Lpos)
of Raptorlox/lox (black line) and
Raptorlox/lox;Foxn1Cre(greyline) mice
into RAG2 -/- recipients. Induction
of wasting disease represented the end
point of the experiment and was defined
by a weight loss of 20% of the maximum
body weight. Per experimental group
5 RAG2 -/- mice were used. In the
group of 400,000 transplanted Tna¨ıve
cells generated in Raptorlox/lox mice,
one RAG2 -/- mouse died unexpectedly
without previous weight loss at day 38.
3.4.4 Suppressive potential of Treg
Next, the ability of Raptorlox/lox;Foxn1Cre mice to generate Treg cells was in-
vestigated. The absolute number of peripheral Treg cells in Raptor
lox/lox;Foxn1Cre
mice was significantly lower when compared to the number of regulatory
T-cells in wild type animals. This decrease may reflect a reduced T-cell pro-
duction in Raptorlox/lox;Foxn1Cre mice or, alternatively, may be caused by
a diminished intrathymic de novo generation. To address these possibilities
Treg were analysed in the thymi of wild type and mutant mice. In 7 week
old mice, the frequency of regulatory T-cells within the CD4pos thymocytes
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was 2% ±0.2% in comparison to 0.6% ±0.1% (***p < .005) in mutant mice
(Fig. 3.31 A (i) and (ii)). To assess the functionality of the regulatory T-
cells generated in Raptorlox/lox;Foxn1Cre mice, a Treg suppression assay was
performed. Sorted CD4pos effector T-cells (expressing a CD45.1 congeni-
tal marker) were sorted and cultured for 3 days in the presence of α-CD3
(1µg/ml) and different cell numbers of Treg isolated from wild type and
mutant were added. Treg isolated from mutant mice displayed a better in
vitro suppressive potential than wild type Treg when tested at a ratio of
2:1 and higher in comparison to cells from wild type mice (Fig. 3.31 B (i)
and (ii)). To further investigate this finding, Treg subsets expressing CD103
and/or CD278 (i.e. ICOS, Inducible T-cell COStimulator) were investigated
as the use of these cell surface markers identifies four separate but interre-
lated groups of cells. CD103/ICOS double positive Treg best suppress the in
vitro proliferation of activated CD4pos effectors cells and their relative fre-
quency increases with the degree of peripheral lymphopenia (Barthlott et al.,
manuscript in preparation). This Treg subpopulations was over-represented
in mutant mice (33.3% ±2.8% in mutant mice in comparison to 13.6% ±3.5%
in wild type mice ( ***p < .005)). This result provides a possible explanation
for the absence of spontaneous autoimmunity in Raptorlox/lox;Foxn1Cre mice
(Fig. 3.31 B). To further verify the function of T-cells selected in a thymic
microenvironment devoid of Raptor expression by TEC, experiments are
now underway in wild type and mutant mice to deplete their Treg in vivo
and to monitor the incidence and the kinetics of autoimmunity.
3.4.5 Incidence of autoimmunity
To investigate whether T-cell development in the context of epithelia de-
void of mTORC1-signalling leads to an increased incidence of autoimmunity,
possible target organs of such a response against self-antigens were isolated
from 13 weeks old wild type and Raptorlox/lox;Foxn1Cre mice, and screened
for the presence of lymphoid infiltrates using hematoxylin and eosin staining
(Fig. 3.32).
The selected organs represent some of the most frequently targeted or-
gans in autoimmune pathologies; eye and optic nerve (rheumatoid arthri-
tis, multiple sclerosis), pancreas (autoimmune pancreatitis), salivary glands
(Sjo¨gren’s syndrome) and thyroid (Hashimoto’s thyroiditis).
Cellular infiltrates could not be detected in any of the tissues analysed.
Together with the observation that the lifespan of Raptorlox/lox;Foxn1Cre
mice is identical to the one of wild type littermates, this data suggests that
lack of Raptor in TEC is not linked to an increased risk of developing auto-
immune pathologies.
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Figure 3.31: Raptorlox/lox;Foxn1Cre mice generate fewer but more potent Treg in
comparison to wild type; (A) (i) Flow cytometric detection of regulatory T-cells in thymi of
7 week old Raptorlox/lox and Raptorlox/lox;Foxn1Cre mice. Treg were identified based on the
expression of CD4, CD25 and FoxP3. Cells were gated on CD4pos thymocytes (ii). Frequencies
of Treg within CD4pos cells in mutant and wild type mice. (B) (i) Treg suppression assay
displaying Carboxyfluorescein succinimidyl ester (CFSE) proliferation profiles of sorted wild type
(CD45.1) Tna¨ıve CD4
pos cells cultured with α-CD3 (1µg/ml) and sorted Treg of Raptorlox/lox
(white) or Raptorlox/lox;Foxn1Cre mice (grey) mice in the dilutions indicated (ratios are Tna¨ıve :
Treg). Analysis was performed after 3 days in culture. (B) (ii) Suppressive potential of Treg at
different dilutions illustrated in bar graph. (C) Representative FACS plots of Treg subpopulations,
distinguished by the cell surface expression of Inducible T-cell COStimulator (ICOS) and CD103.
Cells were isolated from lymph nodes of 7 weeks old Raptorlox/lox and Raptorlox/lox;Foxn1Cre
mice. Values were indicated as mean plus SD. Each experimental group consisted of at least 3
mice. p values were determined by Student’s t test with *p < .05; **p < .01; ***p < .005)
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Figure 3.32: Organ sections of aged Raptorlox/lox;Foxn1Cre mice show no signs of
autoimmunity; Hematoxylin and Eosin staining of divers organ sections (8 µm) of 13 weeks old
female Raptorlox/lox mice (upper panel) and Raptorlox/lox;Foxn1Cre mice (lower panel). The
following organs were used: eyes (i), optic nerve (ii), pancreas (iii), salivary gland (iv), and
thyroid (v). Scalebar indicates 200µm.
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3.5 Gene expression profiling in Raptor-sufficient
and -deficient TEC
To address the perceived differences in the role of Raptor for the biology
of TEC during embryonic versus postnatal epithelial development, and the
difference of Raptor’s impact on cortical versus medullary TEC, a gene ex-
pression analysis was carried out, comparing Raptor-sufficient with Raptor-
deficient TEC. The objective of this analysis was to gain insight into the
availability and differential representation of signalling pathways linked to
the phenotypic and functional differences observed between TEC that ex-
press Raptor and those that are deficient of Raptor.
The Affymetrix Mouse Gene 1.0 ST Array was performed on wild type
and mutant TEC that were isolated from fetal thymi at E16 and postnatal
thymi at 2 weeks of age. The postnatal time point was chosen, as 2 weeks
old mutant thymi were already hypoplastic but did not yet display signifi-
cant differences in the relative representation of TEC subpopulations within
cTEC and mTEC. Therefore, the risk to obtain differences between wild
type and mutant cTEC and mTEC, which would be linked to the specific
TEC-subsets overrepresented in Raptor-deficient mice, was minimized. The
TEC of 2 weeks old mice were separated into cTEC and mTEC. Since the
epithelial compartment of thymi at E16 constitutes mostly cTEC, fetal TEC
were not separated further.
The detailed analysis of gene networks and signalling pathways that are
differentially represented between embryonic and post-natal TEC as well
as between post-natal cortical and medullary TEC has been initiated and
shown to be feasible. Preliminary data of the gene expression analysis re-
vealed significant changes in the number of transcripts specific for central
molecules of the canonical Wnt signalling pathway in adult cTEC, among
them wingless-type MMTV integration site family, member 3A (Wnt3a) and
the lymphoid enhancer-binding factor 1 (LEF1). A further in-depth analysis
is beyond the scope of this thesis. Subsequent work in this direction will
focus in particular on pathways related to cell size, proliferation and the
expression of chemokines and cytokines that are essential for the interaction
with developing thymocytes.
mTOR and the canonical Wnt pathway
Further analyses focussed on the canonical Wnt signalling pathway, as it was
affected by the inhibition of mTORC1 in TEC and has been linked to ep-
ithelial cell fate, growth and differentiation (Miller, 2002). Moreover, stimu-
lation of the canonical Wnt signalling pathway in TEC by secretion of Wnt
glycoproteins increases the expression of Foxn1 (Balciunaite et al., 2002).
Therefore, Wnt molecules provide regulatory signals critical for thymic func-
tion.
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Figure 3.33: TEC subpopulations of Raptorlox/lox;Foxn1Cre mice display an altered
expression of β-catenin compared to wild type mice; A (i) Histograms display β-catenin
signal in different TEC subpopulations (cTEChi, cTEClo, mTEChi, mTEClo) of 7 weeks old
Raptorlox/lox and Raptorlox/lox;Foxn1Cre mice. A (ii) Frequencies of β-cateninhi cells in the
respective TEC subset are depicted in bar graphs as mean values plus SD. Each experimental
group consisted of at least 3 mice. p values were determined by Student’s t test with *p < .05;
**p < .01; ***p < .005)
Canonical Wnt signalling causes stabilization of β-catenin, which enables
its translocation to the nucleus, where it interacts with the transcription
factors that regulate expression of target genes. To measure Wnt signalling
activity, β-catenin expression was detected in wild type and mutant TEC
using flow cytometry. β-catenin expression intensities differed in TEC de-
pending on the amount of MHCII cell surface expression and the TEC cell
type (Fig. 3.33 A (i, ii)). In wild type and mutant mice the relative number
of β-cateninpos TEC was highest in the population of mTEChi when com-
pared to the other TEC subsets. However, mutant mice displayed in gen-
eral a significantly reduced frequency of β-cateninpos cells within all TEC
subsets with the exception of cTEChi when compared to wild type TEC
populations (Fig. 3.33 A (i, ii)). This result demonstrates that mTORC1
activity is correlated with alterations in β-catenin expression specific for
TEC subpopulations.
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Chapter 4
Discussion
Regular thymic size requires both mTOR complexes
The goal of this study was to determine the role of the mTOR signalling
pathway for the development, maintenance and function of thymic epithelia.
As mTOR consists of two functionally different complexes (mTORC1 and
mTORC2), three individual tissue-specific conditional knockout mice were
generated, namely animals lacking either mTORC1 (Raptorlox/lox;Foxn1Cre
mice), mTORC2 (Rictorlox/lox;Foxn1Cre mice), or both multi-protein com-
plexes (Rictorlox/loxRaptorlox/lox;Foxn1Cremice). The availability of these
mice with a loss of Raptor, Rictor or the expression of both proteins in
thymic epithelia allowed to interrogate the function of these molecules sep-
arately in the context of thymic function.
All three mouse models of partial or complete mTOR-inhibition dis-
played a significant change in thymic size, composition and functional com-
petence at the age of 2 weeks. These results thus demonstrated the impor-
tance of intact mTOR signalling for thymic epithelial biology.
The concept that mTOR controls cellular (Fingar et al., 2002), and thus
organ size (Csibi and Blenis, 2012; Cloe¨tta et al., 2013) is indeed consistent
with the observation that the absence of Raptor and/or Rictor results in
significant thymic hypoplasia. However, obvious differences in the sever-
ity of the thymic phenotype exist, when comparing the consequences of a
TEC-targeted loss in mTORC1, mTORC2 or a general mTOR inhibition.
Though the single loss of Raptor expression did not affect the thymic size in
neonatal mice, the loss of Rictor and especially the combined loss of Raptor
and Rictor reduced thymic cellularity. Later in life, Raptor-mutant mice also
displayed a significant decrease in thymic cellularity. Thus, the absence of
Raptor cannot be compensated after birth by the presence of Rictor whereas
the latter is essential for both embryonic as well as post-natal TEC devel-
opment. The concomitant and parallel availability of mTORC signalling by
complex 1 and 2 is therefore required though with a different importance at
distinct developmental stages. However, the stronger phenotype observed
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in mice completely devoid of mTOR signalling implies that there is par-
tial redundancy in the function of mTORC1 and mTORC2 during thymus
organogenesis and post-natal organ maintenance.
mTORC1 and mTORC2 are interdependent in the context of TEC
biology
mTORC1 and mTORC2 have initially been thought to be functionally inde-
pendent though both mTOR complexes have now been shown to influence
each others activity indirectly. Indeed, mTORC1 regulates via an internal
feedback loop not only its own activity but also that of mTORC2. The
steps involved in this negative feedback loop include the inhibition of PI3K
downstream of the mTORC1 effector S6 kinase and the suppression of the
growth factor insulin receptor substrate-1 (IRS1) function. Because growth
factors act upstream of mTORC2 and stimulate its signalling activity, the
suppression of IRS1 mediated signals dampens mTORC2 activity (Harring-
ton et al., 2004; Um et al., 2004). Additionally, it was shown that mTORC1
activation promotes the phosphorylation of Rictor, and thus negatively reg-
ulates mTORC2 and Akt signalling (Julien et al., 2010). Conversely, it
was found that Raptor-deficient bone marrow-derived dendritic cells display
an enhanced mTORC2 activity, which in turn results in an increased Akt
activity (Kellersch and Brocker, 2013).
However, an effect of mTORC2 on mTORC1 signalling activity has so
far not been described. Although Akt regulates not only signalling events
upstream of mTORC1 but also constitutes a substrate for mTORC2, it was
shown that phosphorylation of Akt at Ser 473 - specifically mediated by
mTORC2 - does not have an impact on the regulation of mTORC1. There-
fore, mTORC2 is not considered to signal upstream of mTORC1 (Jacinto
et al., 2006).
These examples show a mutually specific relation between mTORC1 and
mTORC2 activity and provide some explanations for the differential effect
of a loss of mTORC1 and mTORC2 signalling in the three mutant mouse
models studied.
Effects of mTORC1-deficiency in TEC manifests postnatally
To investigate in depth the morphological, functional and molecular changes
that ensue as a consequence of impaired mTOR signalling, my study fo-
cussed on the specific role of Raptor for the mouse thymic epithelia. The
loss of Raptor was engineered to occur at around day 12 to 12.5 during
embryogenesis (E12-12.5) since Raptorlox/lox and/or Rictorlox/lox;Foxn1Cre
mice were crossed with the Foxn1-Cre transgenic mouse line, which starts
Cre expression from gestational day 11.5 onwards (Zuklys et al., 2009).
A significant decrease in total thymic cellularity was only observed in
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Raptorlox/lox;Foxn1Cre mice in comparison to controls once the mice were 1
week of age or older. The unchanged thymic cellularity early in development
and immediately after birth was not due to a lack in recombination since
Raptor transcripts and protein (as measured by qPCR and immunohistol-
ogy) were reduced as early as E14 and absent by E16.5. Assuming that any
remaining Raptor activity was significantly decreased or altogether lost, sev-
eral explanations may account for the relatively late onset of a distinct phe-
notype in Raptorlox/lox;Foxn1Cre mice. Firstly, prenatal thymic development
may proceed independently of a need for mTORC1 signalling. Secondly,
prenatal mTORC2 activity could fully compensate for the loss of Raptor
function. Finally, a prenatal loss of Raptor function may only become man-
ifest one week after birth at the phenotypic level though molecular changes
may already be apparent earlier.
The last explanation cannot easily be distinguished from a scenario in
which early thymic development is independent of mTORC1 at all. Indeed,
it has been established that thymocyte haematopoietic precursor seed in pe-
riodic waves to the thymic microenvironment and that only cells that have
entered the primordium before E13 undergo proliferation and differentiation
during the fetal period. In contrast, precursors that have entered the thymus
later will have to await their turn in contributing to thymic T-cell develop-
ment, which has been shown to occur in the weeks after birth (Le Douarin
and Jotereau, 1975). Thus, the sequential seeding and expansion of T-cell
precursors may partially account for the “delayed” (i.e. post-natal) onset of
thymic hypoplasia in Raptorlox/lox;Foxn1Cre mice, though features other than
low thymocyte numbers are the consequence of a loss of Raptor expression
in TEC.
Loss of Raptor in TEC is dispensable for initial mTEC formation
but is needed for their maintenance
A significant decrease in the absolute number of mTEC is apparent in
Raptorlox/lox;Foxn1Cre mice as early as in the second week of life. This pro-
gressive decrease is accompanied by a replacement with mesenchymal fibrob-
lasts. The mentioned timing in the loss of mTEC suggests that mTORC1
signalling is dispensable for the initial formation of the epithelial scaffold of
the medulla, a process that depends amongst others on RelB- (Burkly et al.,
1995) or lymphotoxin β receptor-mediated signals (Boehm et al., 2003).
The selective decrease in the absolute cell number of mTEC in Raptor-
deficient mice was unexpected. This observation may link to the fact that
mTEC devoid of Raptor display a decreased proliferation rate in comparison
to wild type. This result is in keeping with a role of mTOR signalling in
cell proliferation and its pharmacological blocking using Rapamycin, which
results in an arrest in cell-cycle progression in the G1 phase (Dowling et al.,
2010). Still it remains to be resolved, why cTEC are more resilient to the
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loss of mTORC1. Gene expression profiling may provide molecular hints to
this difference, which can further be investigated.
Raptor-ablation in TEC leads to a relative overrepresentation of
AIREpos mTEC
The reduction of mTEC in Raptorlox/lox;Foxn1Cre mice affects the separate
mTEC subpopulations differently. Mature mTEC can be distinguished into
AIRE-expressing and AIRE-negative epithelia and it is the former that is
progressively overrepresented in mTEC of Raptorlox/lox;Foxn1Cre mice.
Early embryonic differentiation of AIREpos mTEC involves receptor acti-
vator of NF-κB (RANK) interactions with its corresponding ligand (RANKL)
provided by CD4pos3neg lymphoid tissue inducer cells (LTi) (Rossi et al.,
2007), (White et al., 2008). The number of AIRE expressing mTEC in
Raptorlox/lox;Foxn1Cre mice is unperturbed at both embryonic and newborn
stages. This finding implies furthermore that mTORC1 signalling is not
required for the developmental events in TEC differentiation that rely on
RANK-RANKL interactions for the mechanisms that secure the presence of
LTi in the embryonic thymus. However, the molecular and cellular require-
ments for the regular differentiation and maintenance of AIREpos mTEC in
adult mice are still incompletely defined.
A possible explanation for the increased frequency of adult AIREpos
mTEC in mutant mice may be provided by 3D visualization of the thy-
mus, which demonstrated that AIREpos mTEC tend to congregate in the
medullary area of the corticomedullary junction (CMJ) (Irla et al., 2013). In
Raptorlox/lox;Foxn1Cre mice, the total number of mTEC is reduced. However,
its distribution appeared much more dispatched than in wild type thymi. In
this context, it would be interesting to evaluate whether the surface contact
between medulla and cortex in mutant mice is comparable to that of wild
type mice or whether the more fragmented spreading of mTEC that was
observed in mutant mice results in a larger contact zone between cortex and
medulla according to the principle of surface expansion and therefore in a
higher frequency of AIRE-expressing mTEC.
Raptor-ablation in TEC favors the overrepresentation of MHCIIhi
cells in TEC
In Raptorlox/lox;Foxn1Cre mice, the frequency of MHCIIhigh cells is increased
in both TEC subsets. MHC class II expression in TEC depends strictly on
the activation of the class II, major histocompatibility complex, transacti-
vator (CIITA) (Chang et al., 1994), which can be modulated by environ-
mental stimuli, such as interferon γ (Steimle et al., 1994). Recently, the
inhibition of mTORC1 signalling via treatment with rapamycin was corre-
lated with an increased surface expression of MHCII on professional antigen
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presenting cells in vitro and in vivo (Schmid and Mu¨nz, 2007; Jagannath
et al., 2009). The measurement of autophagic activity in both wild type
or Raptor-deficient TEC revealed a positive correlation between MHCII ex-
pression and autophagy, which is in keeping with this previously noted as-
sociation of MHCII-upregulation and autophagy. Therefore, a sequence of
events is likely, whereby the loss of mTORC1 signalling results in MHCIIhi
expression through promotion of autophagy.
Loss of Raptor expression in TEC impacts on thymopoiesis
In view of the many phenotypic changes, I also probed the function of TEC
devoid of regular Raptor-expression.
T-cell maturation is a cell non-autonomous process, which requires the
interaction with thymic epithelia. At first view, lack of mTORC1 signalling
in TEC does not interfere with this interaction and is compatible with the
generation of normal frequencies of CD4pos and CD8pos thymoyctes. A more
detailed analysis, however, revealed alterations in the maturation of posi-
tively selected SP thymocytes from mutant mice, which resulted in an in-
creased frequency of SP cells that are immature. The analysis of BrdU-
incorporation after a 4 days chase showed identical frequencies of labelled
SP cells in both strains of mice, which indicated that an altered kinetic
in the transition from the DN to the SP stage was not the reason for the
overrepresentation of immature SP thymocytes in mutant mice. An alter-
native explanation for the observed increase in immature SP thymocytes
is based on the fact that Raptorlox/lox;Foxn1Cre mice display significantly
fewer mTEC. As mTEC are functionally related to negative selection of
self-reactive thymocytes, the paucity of these cells in Raptorlox/lox;Foxn1Cre
mice could result in a decreased efficiency in the elimination — and therefore
in an relative increase — of immature SP cells.
Since the relative increase in the immature SP cells was accompanied by
a decrease in mature SP cells, the observed alterations could also arise from
an accelerated egress of mature SP cells. Compatible with this hypothesis is
the observation that the frequency of S1P1pos cells mature SP thymocytes
was significantly decreased in Raptorlox/lox;Foxn1Cre mice. This reduction
correlated also with a higher vascular density and an increased number of
pericytes in the medulla of Raptor-mutant mice. As pericytes promote thy-
mocyte egress (Zachariah and Cyster, 2010) by producing S1P, the latter
finding could additionally support the concept, that the exit of mature SP
cells is accelerated in mice with a TEC-targeted inhibition of mTORC1.
However, to identify the reason for the observed shifts in the frequencies of
immature and mature thymocytes in Raptorlox/lox;Foxn1Cre mice the transit
time of post-selection thymocytes in the medulla of wild type and mutant
mice needs to be defined.
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Raptorlox/lox;Foxn1Cre mice are lymphopenic and display changes in
regulatory T-cells
Raptorlox/lox;Foxn1Cre mice suffered from peripheral lymphopenia due to re-
duced output of na¨ıve T-cells and had significantly fewer intrathymically
generated regulatory T-cells in relative and absolute terms. Moreover, there
were indications that negative selection was less efficient in thymi of Raptor-
deficient mice when compared to wild type mice.
Analysis of CD4pos T-cell subpopulations in adult wild type and mutant
mice revealed further that within the CD4pos cells, memory T-cells mice
were overrepresented in Raptorlox/lox;Foxn1Cre mice. The latter observation
is ascribed to a well-known process, termed homeostatic proliferation, dur-
ing which the expansion of few T-cell in a lymphopenic mouse is promoted
due to an abundance of niches and cytokines. Typically, these homeostati-
cally expanded T-cells show an activated, memory-like phenotype, which is
marked by the expression of CD44 (Goldrath et al., 2000; Cho et al., 2000).
Homeostatic proliferation can result in the expansion of auto-reactive T-cell
clones. Despite these observations, Raptorlox/lox;Foxn1Cre mice did not dis-
play any signs characteristic for the development of autoimmune diseases or
a decreased lifespan when compared to wild type mice.
This finding might be explained by the observation that lymphopenia is
associated with a relative over-representation and an increased potency of
Treg (Barthlott et al. manuscript in preparation). Indeed, quantification
of peripheral regulatory T-cells revealed at the age of 2 weeks and older
both a significantly increased frequency of Treg within the CD4
pos T-cells
of mutant mice, and an increased suppressive potential of Treg in vitro from
Raptorlox/lox;Foxn1Cre mice. The latter finding correlated with an overrepre-
sentation of a Treg subsets in mutant mice which express CD103 and ICOS
that has been described to suppress activation of T-cells best. Taken to-
gether, these data suggest that peripheral tolerance mediated by a Treg
subpopulation that is overrepresented in Raptorlox/lox;Foxn1Cre mice can ac-
count for the absence of autoimmunity, despite lymphopenia and an im-
paired generation of central tolerance in these mice.
Raptorlox/lox;Foxn1Cre mice display altered activity of canonical Wnt
signalling in TEC
The frequency of β-cateninpos TEC were significantly decreased in all TEC
subsets of mutant mice with the exception of cTEC expressing high amounts
of MHCII.
Wnt glycoproteins regulate Foxn1 expression (Balciunaite et al., 2002),
and stabilization of β-catenin in TEC results in a block in thymus develop-
ment and a loss of TEC identity (Zuklys et al., 2009). These implications
of Wnt signalling in TEC biology suggest that the dysregulated levels of
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β-catenin may contribute to the changes observed in the thymic microen-
vironment of Raptorlox/lox;Foxn1Cre mice. Thymi of mutant mice were hy-
poplastic and displayed in comparison to wild type thymi already at young
age a remodelling of the organ with an increase in fibroblasts. These as-
pects — reminiscent of premature aging — may be also influenced by alter-
ations of the level of β-catenin as the suppression of β-catenin dependent
Wnt signalling in TEC was implicated in the initiation of thymic senescence
(Varecza et al., 2011). The level of cytoplasmatic β-catenin is posttransla-
tional strictly controlled by proteins that facilitate its degradation (Luckert
et al., 2011), such as GSK3β. Therefore, a failure in GSK3β inactivation
may account for decreased levels of β-catenin.
mTOR signalling can inhibit GSK3β activity through S6Kinase-mediated
phosphorylation, which could provide an explanation for a lack of GSK3β
inactivation in Raptorlox/lox;Foxn1Cre mice. However, it was shown that
such a mechanism would only work if Akt-mediated inhibition of GSKβ is
blocked as well. Since mTORC1 inhibition increases Akt activity (Zhang
et al., 2006), the aforementioned mechanism is not a likely explanation for
the decreased levels of β-catenin. Therefore, a different mTOR-dependent
process needs to be responsible for this effect. Gene expression profile anal-
ysis revealed several candidates influencing the Wnt signalling pathway and
may thus guide future understanding of the observed alterations.
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Chapter 5
Conclusion
mTOR signalling is essential for TEC differentiation and maintenance. How-
ever, there is a differential requirement for the separate mTOR complexes
with regards to TEC biology. Whereas mTORC1 signalling is dispensable for
thymic organogenesis and further development during the embryonic stage,
the absence of mTORC2 leads already prenatally to a reduced thymic cellu-
larity. Despite their individual roles in TEC biology, both mTOR complexes
display also a partial functional redundancy, as their combined loss results
during both neonatal and postnatal stages in a phenotype that is stronger
when compared to single mutant mice.
The absence of mTORC1-signalling at post-natal stages results in thymic
hypoplasia and an increased fibrotic remodelling of the thymic microenvi-
roment. Further changes are characterized by a significant reduction in
medullary but not cortical TEC cellularity, a diminution of cell size, de-
creased TEC cell cycle activity, and a reduction in the transcription of
TEC-specific chemokines that control the attraction of T-cell precursors to
the thymus. Although the main steps during T-cell development are inde-
pendent of the presence of mTORC1, its signalling in TEC is required for
thymocyte selection and maturation.
In view of these essential thymic functions that are disturbed by the
disruption of mTORC1 and mTORC2, any efforts integrating this pathway
for medical therapeutic purposes will need to assure that disruption of T-cell
maturation and thymic function are not an inadvertent complication.
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